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Abstract 
The involvement of retinoic acid (RA) in nervous system regeneration has been well 
documented, though the precise cellular and molecular mechanisms have not yet been fully 
determined. During regeneration, RA can exert trophic support for cells, as well as tropic 
effects to guide neurite outgrowth. Cultured neurons of the Lymnaea central nervous system 
(CNS) have previously been used to investigate the role of RA in neurite outgrowth and 
growth cone guidance. Recently however, a novel phenomenon has been identified, in which 
neurite outgrowth occurs from cut nerves of Lymnaea CNS “floating” on the surface of 
cultured medium. In this study, I examined whether RA could induce or guide neurite 
outgrowth from this novel preparation. Unlike previous findings with cultured neurons, there 
was a lack of consistent effects of 9-cis and all-trans RA in promoting neurite outgrowth 
from the floating CNS. However, the growth cones of these floating neurites were found to 
turn toward a local source of RA, indicating for the first time, that they are capable of 
responding to guidance cues, even in the absence of adhesion to a solid substrate. The 
cellular mechanisms of RA-induced growth cone turning were then conducted on cultured 
neurons. I demonstrated that various retinoid receptor agonists could mimic the chemotropic 
effects of RA, providing further evidence for a potential role of retinoid X receptor and 
retinoic acid receptors in growth cone turning. I also examined potential downstream 
effectors involved in this chemotropic response to RA and provided the first evidence that the 
intracellular signaling pathway likely involves the Rho GTPase, Rac. However, it was also 
shown that the involvement of Rac in mediating the RA-induced growth cone turning 
differed depending on whether the turning was induced by endogenous or synthetic retinoids, 
and also whether the growth cones were still attached to the cell body or not. Overall, these 
data provide new insights into the mechanisms by which retinoids affect neurite outgrowth 
and growth cone behaviour during regeneration of the nervous system.  
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1.01 General Introduction 
The establishment of precise connections in the central (CNS) and peripheral (PNS) 
nervous system throughout regeneration is important for their correct functioning. During 
regeneration, damaged nervous tissues regrow and repair. Retinoic acid is a molecule that has 
been implicated in exerting trophic effects to support the outgrowth of neurites during 
regeneration (Dmetrichuk et al. 2005; Dmetrichuk et al. 2006). A trophic effect refers to the 
stimulation of growth and/or elongation of neurites. Additionally, retinoic acid can exert 
tropic effects and act as a chemoattractant in vertebrates and invertebrates (Dmetrichuk et. 
al., 2005; 2006). A chemoattractant is a chemical molecule that can guide neurite processes 
(usually toward an appropriate target) during development or regeneration, thus generating a 
tropic (or turning) response. The involvement of retinoic acid in the regeneration of both the 
CNS and PNS has been well documented (Maden 2007), though its precise role is yet to be 
determined. Hence, it is essential to gain a better understanding of the underlying 
mechanisms by which retinoic acid directs neurite outgrowth during regeneration.  
In contrast to the adult mammalian CNS, adult invertebrates such as the mollusc 
Lymnaea stagnalis retain the ability to regenerate CNS neurons. Also, Lymnaea possesses a 
relatively simplistic and well-characterized nervous system and is a well-established model 
system to study regeneration. We have used Lymnaea to study both the trophic and 
chemotropic effects of retinoic acid on neurite outgrowth from the CNS and from cultured 
neurons. Comparing the effects of retinoid signalling in the regenerating invertebrate nervous 
system with its various effects in vertebrates, may allow us to gain a better understanding of 
its role in enhancing and guiding neurite outgrowth.  
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Literature Review: 
1.02 Retinoic Acid Synthesis 
Retinoic acid is the most biologically active, naturally occurring member of a family 
of retinoids derived from Vitamin A. Retinoic acid is obtained from the diet in the form of 
carotenoids (from the intake of fruits and vegetables), or in the form of retinyl esters (from 
the tissue of animals that have already ingested and metabolised carotenoids). These 
compounds are then stored in the body, mainly in the liver, in the form of retinyl esters 
(Blomhoff and Blomhoff, 2006). When required by cells, the stored retinyl esters are 
converted to retinol and bind to retinol-binding proteins (RBPs) for transport in the 
bloodstream to specific target areas (Maden, 2007). Retinol then enters the cell, via a 
transmembrane protein known as STRA6 (stimulated by retinoic acid gene 6), and binds to 
cellular RBPs (CRBPs) (Niederreither and Dollé, 2008). CRBPs facilitate the conversion of 
retinol to retinal via alcohol dehydrogenase (ADH). The enzyme retinal dehydrogenase 
(RALDH) then irreversibly metabolizes retinal to retinoic acid via oxidation (Duester, 2000). 
Cellular retinoic acid-binding proteins (CRABPs) can facilitate the transport of retinoic acid 
within the cell (autocrine signaling), or out of the cell (to signal in paracrine manner). In the 
autocrine signaling process, retinoic acid can enter the nucleus and bind to ligand activated 
nuclear transcription factors, known as retinoid receptors. These retinoid receptors bind to a 
sequence of DNA called a retinoic acid-response element (RARE), and with the aid of a 
range of co-activators or co-repressors, can ultimately lead to changes in gene activity. The 
important function of controlling the levels of retinoic acid in the body is established by 
enzymes from the CYP26 family (cytochrome P450 enzymes), which can catabolise retinoic 
acid into polar metabolites (Reijntjes et. al., 2005; Figure 1).  
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Figure 1. The retinoic acid synthesis pathway. Vitamin A (retinol) can be stored in the form of 
retinyl esters or transported into cells and converted via a metabolic reaction, involving alcohol 
dehydrogenases (ADHs) and retinaldehyde dehydrogenases (RALDH s), into retinoic acid. Retinoic 
acid can then act in an autocrine fashion and regulate gene transcription in the cell that synthesized it, 
or it can act in a paracrine manner, regulating the transcriptional activity of genes in neighboring 
target cells. The degradation of retinoic acid by Cyp26 enzymes serves to control the levels of retinoic 
acid in tissues (Modified from Niederreither and Dolle, 2008). 
 
1.03 Retinoic Acid Signalling  
Retinoic acid’s primary mode of action thus involves signalling through the nuclear 
receptors known as retinoic acid receptors (RARs) and retinoid X receptors (RXRs). RARs 
and RXRs are thought to be activated by the binding of different retinoic acid isomers 
(retinoids with the same molecular formula but different chemical structures). Studies on 
vertebrates have found that RARs can be activated by both 9-cis and all-trans retinoic acid 
(Allenby et. al., 1994). RXRs almost exclusively bind 9-cis retinoic acid, though all-trans 
retinoic may bind to some RXRs but with lower affinity compared to its binding to RARs 
(Heyman et. al., 1992). Once bound to the receptors, the ligands can induce 
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heterodimerization of RAR and RXR. RXR can also function as a homodimer, or RXR can 
also form heterodimers with other receptors such as the Vitamin D and thyroid receptors (Yu 
et. al., 1991). Hence, the possibility for homodimerized activity of RARs and RXRs exists, in 
which each receptor is individually activated by its respective ligands (Figure 2).  
 
Figure 2. Retinoic acid’s classical mechanism of action in the cell nucleus. This involves binding 
to nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs). Vertebrate RXRs 
demonstrate a preference for 9-cis retinoic acid, whereas RARs can be activated by both 9-cis and all-
trans retinoic acid. All-trans retinoic acid may also bind to RXRs, but at a lower affinity (represented 
by the dotted arrow) compared to RARs. Following the binding of retinoic acid, these receptors 
heterodimerize or homodimerize then bind to a retinoic acid-response element (RARE) sequence to 
regulate gene activity (Modified from Simões-Costa et. al., 2008). 
 
The two active isomers of retinoic acid, all-trans and 9-cis retinoic acid, have been 
found to exert different effects in some cases, whereas others have determined that both 
isomers can act similarly. Pedersen et. al. (1995) showed that both isomers increased the 
choline acetyltransferase activity and the intracellular levels of acetylcholine in a murine 
septal cell line. Furthermore, all-trans and 9-cis retinoic acid induced similar inhibition of 
proliferation of human neuroblastoma cells (Plum and Clagett-Dame, 1995) and induced 
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similar neurotrophic effects on outgrowth from cultured molluscan neurons (Dmetrichuk et. 
al., 2008).  
In contrast, other studies have determined that all-trans and 9-cis retinoic acid can act 
in a different manner, either in the concentration required or in their effects. For example, 
Han et. al. (1995) found 9-cis retinoic acid to be more potent than all-trans retinoic acid in its 
antiproliferative and differentiation activity in human neuroblastoma cells, and both isomers 
were found to exert different effects on the production of extracellular matrix proteins and 
the proliferation of activated hepatic stellate cells from rats (Hellemans et. al., 1999). All-
trans retinoic acid exerted inhibitory effects on the synthesis of extracellular matrix proteins 
and did not influence the proliferation of these stellate cells. In contrast, 9-cis retinoic acid 
upregulated procollagen I mRNA but did not affect the synthesis of other extracellular matrix 
proteins, and inhibited the proliferation of the hepatic stellate cells (Hellemans et. al., 1999). 
Furthermore, all-trans retinoic acid was found to be more potent in inducing abnormal firing 
activity and reducing intracellular calcium levels of cultured molluscan neurons (Vesprini 
and Spencer, 2014; Vesprini et. al., 2015).  
 
1.04 The Role of Retinoid Signalling During Development  
Retinoic acid has been established to play an essential role in neuronal patterning, 
neural differentiation and axon outgrowth, and contributes to the anteroposterior and 
dorsoventral patterning of the neural plate and neural tube (Maden, 2007). Retinoic acid has 
been detected at various developmental stages in several species, including mouse and chick 
embryos (Chen and Solursh, 1992; Maden, 2000) and axolotl embryos (Monaghan and 
Maden, 2012), and its levels increase during the development of Xenopus embryos (Chen et. 
al., 1994). Several experimental approaches have not only identified and emphasized the 
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presence of retinoic acid during development, but also its regulation.  Excess retinoic acid 
has been shown to cause teratogenesis, targeting several areas of the body including the 
hearts of avian embryos, rats, and hamsters, and the limbs of developing chick, mice, and 
urodeles (Ross et. al., 2000; Zile, 2001). Alternatively, nutritional deficiencies in vitamin A 
as well as retinoid receptor null mutants have led to severe abnormalities in the face, neural 
crest, heart, and nervous system of rats (Dickman et. al., 1997). Similarly, abnormalities in 
the formation of the neural crest and hindbrain, the visual and auditory systems, and several 
other organs were observed in quail, mice and rats, following knock-down of the retinoid 
receptors (Ross et. al., 2000; Zile, 2001).  
 
1.05 The Role of Retinoid Signalling During Regeneration  
Retinoic acid has not only been established to play an essential role in development, 
but also in tissue regeneration following injury or amputation. Some lower vertebrates 
(Prince and Carlone, 2003; Dmetrichuk et. al., 2005) and many adult invertebrates (Syed et. 
al., 1990; Dmetrichuk et. al., 2006),
 
such as the mollusc Lymnaea stagnalis, have retained the 
ability to regenerate their CNS. However, adult neurons of the mammalian CNS, unlike the 
PNS, fail to regenerate. Factors that have been found to contribute to the inability of neurites 
to regenerate in the mature CNS include the presence of inhibitory components, such as 
Nogo and myelin-associated glycoprotein (Mag) (Baldwin and Giger, 2015), as well as a 
decrease in the level of neurotrophic factors present. Moreover, the downregulation of 
retinoic acid signalling is thought to be involved in the loss of regenerative capacity of some 
adult CNS neurons in vertebrates (Maden, 2003). For example, retinoic acid was found to 
induce neurite outgrowth in mouse embryonic neurons and spinal cord but failed to do so in 
adult spinal cord. Yet, when the retinoic acid receptor gene, RARβ2, was introduced into the 
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adult mouse spinal cord, neurite outgrowth was observed (Corcoran et. al., 2002). Hence, 
these data have suggested an important role for retinoic acid signalling in regeneration.  
Further evidence supporting the involvement of retinoic acid in regeneration includes 
the observation that retinoic acid synthesis and signalling are up-regulated following injury in 
several species. The local synthesis and release of both 9-cis retinoic acid and all-trans 
retinoic acid was found in the wound epidermis of the regenerating limbs of newts (Viviano 
et al. 1995). An increase in the activity of the enzyme retinal dehydrogenase 2 (RALDH-2) 
and an upregulation of the cellular retinol-binding proteins-1 and 2 (CRBP-1, CRBP-2) 
components of the retinoic acid signalling pathway, were observed following sciatic nerve 
crush injury in adult rats (Zhelyaznik et. al., 2003). Moreover, experiments with axolotls 
(Maden, 1982; 1983) showed a concentration-dependent effect of retinoic acid on the amount 
of tissue regenerated in the proximodistal axis. Retinoic acid signalling was also detected 
during limb regeneration in the apical epidermis, nerves, and nerve-associated cells in 
transgenic axolotls (Monaghan and Maden, 2012).  
Evidence from various model systems including newt spinal cord tissue (Dmetrichuk 
et al., 2005), embryonic chick dorsal root ganglion neurons (Maden, 1998) and quail 
embryonic spinal cords (Maden et. al., 1996) have also implicated the role of retinoic acid in 
inducing and enhancing neurite outgrowth. Furthermore, in addition to the neurotrophic 
effects of retinoic acid, retinoic acid has also been determined to act as a tropic factor to 
guide neurite outgrowth from regenerating tissue.  
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1.06 The Role of Retinoic Acid in Axon Guidance 
The guidance of neurites to their appropriate targets is accomplished by dynamic 
structures called growth cones, located at the tips of extending neurites. These structures are 
comprised of two regions, the central and peripheral region. The central region consists of 
microtubules and various organelles required for neurite extension (Lowery and Van Vactor, 
2009; Dent et. al., 2011). The second region, the peripheral region, consists of the actin 
filaments required for membrane protrusion. These actin filaments undergo polymerization 
with the addition of actin monomers on one end of the actin filament and depolymerization 
on the other end. This helps to establish the protrusive forces required at the leading edge of 
the growth cone. Additionally, adhesion complexes, involving actin-binding proteins, 
mediate connections between actin and the plasma membrane, and the motor protein myosin 
II generates the traction forces required for growth cone advancement (Gomez and 
Letourneau, 2014).  
The actin filaments in the peripheral region are organised into bundles in the filopodia 
but exist as a meshwork in the lamellipodia (Bamburg et. al., 1992). Filopodia appear as 
finger-like projections whereas lamellipodia appear as veil-like projections (Figure 3). These 
projections possess membrane receptors at their tips and consistently protrude and withdraw 
in order to sense the numerous guidance cues in their environment (Gomez and Letourneau, 
2014). These guidance cues can be attractive or repulsive, inducing growth cone turning 
toward the cue and subsequent neurite extension, or causing growth cone collapse and 
subsequent neurite retraction and/or turning away from the cue, respectively.  
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Figure 3. The neuronal growth cone. The central region (C) of the growth cone is comprised of 
microtubules and various organelles. The polymerization of microtubules at the positive (+) end 
contributes to neurite outgrowth. The peripheral region (P) consists of actin filaments organised in 
bundles in the filopodia and as a meshwork in the lamellipodia. The actin filaments are required for 
membrane protrusion. Taken from Mueller (1999).  
 
Numerous factors are known to act as guidance cues, and these include chemicals 
such as netrins, semaphorins, slits, ephrins, neurotrophins, cytokines, neurotransmitters, 
classical morphogens, growth factors, extracellular matrix molecules, as well as retinoic acid 
(Farrar and Spencer, 2008). Electrical fields can also affect growth cone behaviour and the 
direction of outgrowth (Rajnicek et. al., 2006).  
Maden et. al. (1996) first suggested a chemotropic role for retinoic acid in guiding 
neurite outgrowth, after finding abnormal neurite trajectory in the developing neural tube of 
Vitamin-A deficient quail embryos. Evidence supporting this was provided in 1998 when a 
Dunn chamber was used to generate a stable gradient of all-trans retinoic acid for cultured 
chick dorsal spinal cord neurons. When the gradient was encountered, the regenerating 
neurites changed their orientation and extended towards the higher concentration of retinoic 
acid (Maden et. al., 1998).  More recently, when newt spinal cord explants were co-cultured 
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with a newt limb blastema, many of the neurites extended in the direction of the blastema. 
Neurite outgrowth from the newt spinal cord explants, however, was significantly reduced in 
the presence of a retinoic acid synthesis inhibitor, citral, suggesting that retinoic acid was one 
of the molecules promoting the outgrowth of the neurites towards the blastema (Prince and 
Carlone, 2003). Similarly, Dmetrichuk et. al. (2005) demonstrated that beads soaked in 
retinoic acid and co-cultured with newt spinal cord explants induced preferential directed 
neurite outgrowth towards the source of beads. Altogether, these findings suggest a crucial 
role for retinoic acid in both development and regeneration, particularly in axon guidance.  
 
1.07 Local Response of Growth Cones to Guidance Cues 
Growth cones, mechanically isolated from their cell bodies, have been shown to 
retain their capacity to respond to chemical guidance cues. Preliminary evidence for a local 
response of growth cones was established when isolated growth cones of chick sensory 
ganglion cells were shown to survive and continue to grow in culture (Shaw and Bray, 1977). 
Further evidence was provided when retinal axons of embryonic Xenopus laevis continued to 
display normal pathfinding behaviour, in vivo, following the removal of their somata (Harris 
et. al., 1987), and continued to respond to chemical guidance cues, in vitro (Brunet et. al., 
2005). However, chemotropic guidance of these growth cones was lost following inhibition 
of protein synthesis (Campbell and Holt, 2001). Altogether, these findings suggest that a 
growth cone can function as a semi-autonomous structure and may rely on local protein 
synthesis in order to respond to various guidance cues.  
In fact, key components of the translational machinery (mRNA and ribosomes) are 
present in growth cones which have been shown to be capable of local protein synthesis 
(Campbell and Holt, 2001; Wu et. al., 2005). For example, the chemical guidance cues 
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netrin-1 and Sema3A activate translation initiation factors and stimulate a marked rise in 
protein synthesis in isolated retinal growth cones from Xenopus laevis (Campbell and Holt, 
2001). Chemotropic guidance of these growth cones was lost following the inhibition of 
either protein synthesis or mRNA translation (Campbell and Holt, 2001). Additionally, 
several mRNA transcripts are found localized to growth cones of many different types of 
neurons, including rat dorsal root ganglion and hippocampal neurons (Zhang et. al., 1999; 
Willis et al, 2005), spinal neurons (Yao et. al., 2006) and sympathetic neurons (Lee and 
Hollenbeck, 2003). Particularly relevant to the research conducted in this thesis, Farrar et al. 
(2009) showed that retinoic acid-mediated attractive growth cone turning does not require 
gene transcription (and thus involves non-genomic retinoid signalling). Using cultured 
Lymnaea motorneurons, it was shown that transected neurites (removed from the cell body) 
continued to respond to retinoic acid. Furthermore, it was shown that retinoic acid-induced 
chemoattraction, was dependent on de novo local protein synthesis. Many studies to date, 
have thus established a level of autonomy for growth cones in responding to guidance cues, 
and recent data have now shown the same is true for growth cones responding to retinoic 
acid.  
 
1.08 Rho GTPases, Potential Downstream Effectors in Growth Cone Signalling  
In addition to protein synthesis, the importance of calcium signaling in growth cone 
decisions has been well established (Henley and Poo, 2004). The direction of growth cone 
turning is often dependent on the characteristics of the calcium signals, such as amplitude, 
frequency, localization in the growth cone, and source of the calcium (Gomez and Zheng, 
2006). Calcium changes in the growth cones can be generated by calcium release from 
intracellular stores or influx through plasma membrane channels (or both) (Gomez and 
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Zheng, 2006). Calcium-mediated second messenger signalling pathways in the growth cone 
have been shown to regulate the actin cytoskeleton, thereby modulating the type of behavior 
exhibited upon contact with certain guidance factors (Gomez and Letourneau, 2014).  
The signaling cascades which link the growth cone calcium changes to the 
cytoskeletal movement require further research. One link that has been proposed is a family 
of small guanosine tri-phosphatase binding proteins called Rho GTPases, which includes Ras 
homolog (Rho), Ras-related C3 (Rac) and cell division control protein 42 (Cdc42). Rho 
GTPase signalling occurs downstream of activation of membrane receptors and calcium 
signals, and upstream of effectors of cytoskeletal dynamics. For example, Rho GTPases can 
affect the activity of proteins that regulate the assembly of the actin cytoskeleton, including 
actin-binding proteins (Hall, 2005). Rho GTPases can be activated by numerous guidance 
factors which include semaphorins (Whitford and Ghosh, 2001), netrins (Li et. al., 2002), 
slits (Wong, et al., 2001), ephrins (Wahl et al., 2000), and brain-derived neurotrophic factor 
(BDNF) (Yuan et. al., 2003). This involvement of Rho GTPases in growth cone responses 
has also been widely observed across many species such as Drosophila (Whitford and 
Ghosh, 2001), mice (Li et. al., 2002), rats (Wong, et al., 2001), chicken (Wahl et al., 2000), 
and Xenopos laevis (Yuan et. al., 2003). Specifically, genetic disruption of GTPase activity 
has resulted in growth cone pathfinding defects in Drosophila (Kaufman et. al., 1998) and 
Xenopus (Rajnicek et. al., 2006) embryos. However, whether Rho GTPase signal 
transduction pathways regulate cytoskeletal dynamics during retinoic acid-induced growth 
cone guidance has not yet been examined in any species.  
Spatial and temporal regulation of Rho GTPases in the growth cones contribute to 
both positive and negative turning responses to guidance cues. Rho GTPases are activated 
when guanine nucleotide exchange factors (GEFs) catalyze the exchange of guanosine 
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diphosphate (GDP) for guanosine triphosphate (GTP). They are inactivated upon hydrolysis 
of GTP by GTPase activating proteins (GAPs) (Gao et. al., 2004).  Cdc42 and/or Rac are 
activated on the chemoattractant-facing side of the growth cone, whereas Rho is less active. 
Activation of Cdc42 and Rac stimulates the formation of filopodia and lamellipodia, 
respectively, thereby promoting microtubule elongation and dynamics on the chemoattractant 
side (Kozma et. al., 1997). The mechanisms through which Rho GTPases likely regulate the 
growth cone assembly of the cytoskeleton are still not clear but several effectors have been 
suggested. Rac and Cdc42 have been shown to interact with WAVE (WASP family verprolin 
homologous protein) and WASP (Wiskott–Aldrich syndrome protein)-related proteins, 
respectively, which can activate the Arp2/3 (actin-related protein 2/3) complex to promote 
actin polymerization (Hall, 2005). Rac has also been found to act through cofilin (an actin-
binding protein), to promote protrusion at the front of migrating cells (Gomez and 
Letourneau, 2014).  
During chemorepulsion, the reverse is believed to occur, and Rho is more active. Rho 
has been found to act through Rho kinase (ROCK) to phosphorylate myosin light chain and 
inhibit the myosin light chain phosphatase. Inhibition of the myosin light chain phosphatase 
induces increased activation of myosin II, thereby resulting in the cross-linking of myosin II 
into actin filaments and increased actomyosin contraction. ROCK can also induce LIM 
kinase dependant-phosphorylation and subsequent inactivation of cofilin (Raftopoulou and 
Hall, 2004). In combination with reduced actin turnover, this ultimately leads to growth cone 
retraction and collapse (Raftopoulou and Hall, 2004; Sadok and Marshall, 2014) (Figure 4). 
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Figure 4. Rho GTPases regulate cytoskeleton remodelling. Rho GTPases are activated by guanine 
nucleotide exchange factors (GEFs) which promote the exchange of GDP for GTP. The activated  
Rho GTPases are then capable of interacting with downstream targets or effector proteins that can 
trigger remodelling of the cytoskeleton. The Rho GTPase Rac promotes lamellipodia formation, and 
Cdc42 promotes filopodia protrusion. Rho, however, induces actomyosin contractility. The regulatory 
inactivation of Rho GTPases is achieved by GTPase-activating proteins (GAPs) by stimulating the 
hydrolysis of GTP. It is important to realize that the pathway demonstrated here is an 
oversimplification of what actually occurs within the cell. 
 
Although Rho plays a more dominant role on the chemorepulsive-facing side of the 
growth cone, Rho activity has also been found on the side facing an attractant where Rho 
stimulating actomyosin contraction is believed to help stabilize and steer the protrusion of the 
growth cone (Woo and Gomez, 2006). Rho has also been suggested to promote protrusion 
and the stabilization of actin filaments through a formin-containing protein, called mDia 
(mammalian diaphanous), which binds to and promotes actin polymerization (Watanabe et. 
al., 1999). Additionally, interactions between different Rho GTPases’ signalling pathways 
have been observed and are believed to be involved in regulating the local activation of Rho 
GTPases, as well as the downstream mechanisms involved in growth cone steering and 
protrusion.  
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1.09 Retinoid Signalling in Lymnaea stagnalis 
Retinoic acid and its various signalling components have been detected in the CNS of 
the invertebrate, Lymnaea stagnalis. Evidence from high performance liquid chromatography 
and mass spectrometry experiments has identified that the CNS of adult Lymnaea contains 
both retinoic acid isomers, 9-cis and all-trans retinoic acid, at relatively similar 
concentrations (Dmetrichuk et. al., 2008). Both retinoic acid isomers have been shown to 
induce and enhance neurite outgrowth as well as induce positive growth cone turning in 
Lymnaea neurons (Dmetrichuk et. al., 2006, 2008; Rand, 2012).  
Additionally, findings have strongly suggested a role for both retinoid receptors, RXR 
and RAR, in non-chordate development. Lymnaea RXR (LymRXR) and the putative RAR 
(LymRAR) were shown to be expressed in the developing embryo (Carter et. al., 2010, 
2015), and the normal development of the embryo was altered by the presence of various 
RXR and RAR agonists or antagonists (Carter et. al., 2010; 2015). Disrupted eye and shell 
development was observed in the presence of the RARβ selective antagonist, LE135, and 
pan-RAR antagonist, LE540 (Carter et. al., 2015). Similar deformities were observed 
following the treatment of embryos with the RXR pan agonist, PA024 (Carter et. al., 2010). 
Interestingly, an increase in LymRXR and LymRAR mRNA expression was found throughout 
embryonic development and at stages corresponding with development of the nervous system 
(Carter et. al., 2010; 2015). 
In addition to demonstrating that transected Lymnaea growth cones could respond to 
RA in the absence of their cell bodies, it was also shown that the retinoid receptors were 
present in the growth cones (Carter et. al., 2010; 2015). In particular, Carter et. al. (2010) 
showed a non-nuclear distribution of LymRXR and demonstrated that the RXR agonist 
PA024 induced growth cone turning of both intact and isolated neurites. Furthermore, an 
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RXR antagonist (HX531) blocked the guidance of Lymnaea growth cones towards both 9-cis 
and all-trans retinoic acid (Rand, 2012). LymRAR was also identified in regenerating 
neurites and growth cones (Rand, 2012) and interestingly, immunoreactivity for LymRAR 
was found in both the cytoplasmic and membrane compartments, but not in the nucleus of 
adult neurons (Carter et. al., 2015). The RAR pan-antagonist LE540 was also shown to block 
both all-trans and 9-cis retinoic acid-induced chemoattraction of Lymnaea growth cones 
(Rand, 2012). Collectively, these data establish the presence and role of retinoic acid and its 
receptors in the developing and regenerating CNS of Lymnaea. It is currently hypothesized 
that retinoic acid binds to its receptors localized in the growth cones to mediate non-genomic 
signaling to induce growth cone turning. Though it is known that this process requires both 
calcium influx and local protein synthesis (Farrar et. al., 2009), the downstream effectors 
have not yet been identified. These may however include Rho GTPases, though this has not 
yet been tested in Lymnaea or in any other species. 
 
1.10 Retinoid Receptors are Conserved Between Vertebrates and Invertebrates 
Retinoic acid’s classic mode of action involves signalling through the nuclear RARs 
and RXRs. At least three classes of each receptor have been identified (α, β, and γ) in the 
human, rat, and mouse (Rosewicz et. al., 1995; Ulven et. al., 1998; Zelent et. al., 1998; 
Mangelsdorf et. al., 1992). In vertebrates, RXRs have been found to almost exclusively bind 
9-cis retinoic acid (Heyman et. al., 1992), whereas RARs can be activated by both all-trans 
and 9-cis retinoic acid (Allenby et. al., 1994). RXRs are the predominant invertebrate 
retinoid receptors and have been shown to bind 9-cis retinoic acid in the jellyfish Tripedalia 
cystophora (Kostrouch et. al., 1998), fiddler crab Uca pugilator (Hopkins et. al., 2008), as 
well as the locust Locusta migratoria (Nowickj et. al., 2008). Interestingly, unlike the 
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vertebrate RXRs, the locust RXR also binds all-trans retinoic acid with a similar affinity to 
9-cis retinoic acid (Nowickyj et. al. 2008). Moreover, all-trans retinoic acid was found to 
upregulate the expression of RXR mRNA in the marine sponge Suberites domuncula (Wiens 
et. al., 2003). These findings suggest that the binding affinities of retinoid receptors may 
differ between vertebrates and invertebrates. In Lymnaea stagnalis, the LymRXR has also 
been cloned and has a relatively high overall homology to vertebrate (rat and human) RXRα 
(80%) (Carter et. al., 2010). The LymRXR’s predicted ligand-binding domain shares ~81% 
amino acid identity with rat RXRα, and its predicted DNA-binding domain shares ~89% 
amino acid identity. The LymRXR also shares approximately 97% amino acid identity with 
the RXR of the mollusc Biomphalaria glabrata, which is known to bind 9-cis retinoic acid 
(Bouton et. al., 2005). Although it has not yet been determined whether LymRXR binds 
either ligand, these findings suggested that the LymRXR will likely bind to at least 9-cis 
retinoic acid.  
Non-chordate invertebrates were thought to only possess RXRs (Fujiwara and 
Kawamura, 2003). However, genome screening predicted the presence of an ancestral RAR 
in the annelid, Capitella capitata, and in the mollusc, Lottia gigantean (Albalat and Canestro, 
2009). The first full-length non-chordate invertebrate RAR was cloned from Lymnaea 
stagnalis (LymRAR) (Genbank Accession # GU932671; Carter et. al., 2015). However, 
LymRAR was found to share only 55% sequence similarity with Homo sapiens RARß. 
LymRAR shares 85% amino acid identity with the DNA-binding domain of human RARß, 
and its predicted ligand binding domain shares 58% amino acid identity with that of human 
RARß. RARs have also been cloned from two other molluscs, Thais clavigera (Urushitani et. 
al., 2013) and Nucella lapillus (Guiterrez-Mazariegos et. al., 2014). Interestingly, the Nucella 
lapillus RAR is reported to not bind all-trans or 9-cis retinoic acid (Gutierrez-Mazariegos et. 
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al., 2014). Additionally, the mollusc Thais clavigera RAR (TcRAR) showed no 
transcriptional activity in response to all-trans retinoic acid (Urushitani et. al., 2013). 
However, any potential nongenomic activity of TcRAR would not have been detected by 
these transcriptional assays. Nonetheless, these results could suggest that, even though 
molluscs might possess the retinoic acid signalling machinery, this signalling pathway (at 
least the RAR) might be functioning differently compared to vertebrates. However, the 
ligand binding domain of TcRAR shares only 66% similarity with LymRAR (Urushitani et. 
al., 2013), suggesting that binding affinities of LymRAR may differ compared to TcRAR 
(and/or N. lapillus RAR). It is not yet known whether LymRAR is capable of binding either 
all-trans or 9-cis retinoic acid or whether it may act as a potential heterodimerization partner 
with RXR. 
 
1.11 Lymnaea stagnalis as a Model to Study the Role of Retinoic Acid in Regeneration  
Although the adult mammalian CNS fails to regenerate, some lower vertebrates 
(Prince and Carlone, 2003; Dmetrichuk et. al., 2005) as well as many adult invertebrates 
(Syed et. al., 1990; Dmetrichuk et. al., 2006),
 
such as the mollusc Lymnaea stagnalis, have 
retained the ability to regenerate CNS neurons. Consequently, Lymnaea stagnalis was chosen 
as the model system for my research as it has been used in studying the effects of retinoic 
acid on neurite outgrowth and growth cone guidance (Dmetrichuk et. al. 2006, 2008; Farrar 
et. al., 2009; Rand, 2012). Lymnaea possesses a relatively simplistic nervous system in which 
single neurons are identifiable. Many neurons on the dorsal surface of the CNS have well 
characterized morphology and function, and can be successfully cultured from this animal. 
These molluscan neurons display regeneration in vitro (Syed et. al., 1990) as well as in vivo 
(Syed et. al., 1992). In vitro, large growth cones can be observed at the tips of regenerative 
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neurite processes, making it possible to easily manipulate and observe changes in their 
morphology and behaviour.  
 
1.12 A Novel Preparation: The Floating Lymnaea CNS 
Recently, a novel phenomenon has been identified in our lab, in which neurite 
outgrowth can be observed from cut nerves of Lymnaea CNS “floating” on the surface of 
culture medium. J. Simmons first identified this phenomenon and found that the nerves of the 
CNS must float in order to exhibit outgrowth (Figure 5; unpublished observations). If the 
CNS sunk to the bottom of the dish, they did not exhibit outgrowth. This suggested that 
increased levels of ambient oxygen at the surface and/or surface tension may play a role in 
the outgrowth from these floating nerves. However, previous studies conducted by D. Britt, 
G. Tattersall, and G. Spencer (unpublished findings) showed a greater extent of outgrowth 
from floating nerves of the Lymnaea CNS at lower ambient oxygen levels, suggesting this 
not to be the case. We are yet to investigate the role that surface tension may play in this 
phenomenon. Although we are still unsure of the mechanism by which the floating nerves of 
the intact Lymnaea CNS exhibit outgrowth, this could still prove to be a promising new 
model system in which to study the regenerative behaviour of invertebrate neurons.  
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Figure 5. Neurite outgrowth from a floating Lymnaea nerve. Neurites processes observed from a 
cut nerve ending of a Lymnaea CNS “floating” on the surface of Defined Medium (DM) after 72 
hours. Scale bar= 60 μm. 
 
Subsequently, (unpublished) studies conducted using this preparation found that the 
length of outgrowth from floating CNS continuously increased up to at least 5 days after 
Lymnaea CNS were extracted and floated on culture medium (Karolak, 2014; Racey, 2015). 
Studies also examined the effects of retinoids on this neurite outgrowth, and preliminary 
studies indicated that the effects were different than previously found in cultured neurons. 
All-trans retinoic acid did not induce a significant increase in the extent of neurite outgrowth 
from the floating CNS, when compared to the vehicle dimethyl sulfoxide (DMSO) (Karolak, 
2014). However, 9-cis retinoic acid was found to induce some trophic effects on the neurite 
outgrowth from the floating CNS (Racey, 2015). At higher concentrations (10
-6
 M), 9-cis 
retinoic acid increased the number of nerves showing regeneration as well as increased the 
length of neurite outgrowth (Racey, 2015). It is surprising that the different retinoid isomers 
may affect neurite outgrowth in this model differently than previously shown in cultured 
cells. However, these previous studies examining the effect of the two isomers on the floating 
CNS were not run in parallel, and even used different concentrations of retinoids. A more 
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direct comparison of the abilities of the two isomers to enhance neurite outgrowth is 
therefore required. There are several advantages to using this model preparation to study 
neurite outgrowth, including the ability to observe large-scale changes, which may more 
closely mimic an in vivo response. 
 
1.13 Thesis Objectives 
The main aims of this thesis were twofold. The first aim was to examine the use of 
the floating CNS as a potential model with which to examine the effects of retinoic acid on 
neurite outgrowth in Lymnaea. Based on previous findings from cultured Lymnaea neurons 
(Dmetrichuk et. al. 2006; 2008), we hypothesized that retinoid isomers will enhance neurite 
outgrowth from the floating CNS. Furthermore, since neurites extending from floating 
Lymnaea CNS have been found to grow towards neighboring floating nerve fragments, we 
hypothesized that growth cones at the tip of these floating neurites would sense guidance 
cues and turn towards a local source of retinoic acid.  
Secondly, we sought to investigate the intracellular signalling pathways involved in 
retinoic acid-mediated growth cone guidance. In particular, we focused on examining the 
effects of different retinoid receptor agonists, as well as studying the role of the Rho GTPase 
Rac in retinoic acid-mediated growth cone guidance. Based on previous investigations with 
retinoid receptor antagonists (Rand, 2012; Carter et. al., 2015), we hypothesized that retinoid 
receptors are involved in growth cone turning towards retinoic acid. We therefore predicted 
that the retinoid receptor agonists would mimic the growth cone turning induced by retinoic 
acid. Also, since Rac has been shown to mediate growth cone attraction in response to other 
chemoattractants (Li et. al., 2002; Yuan et. al., 2003), we also hypothesized that Rac would 
be required for growth cone turning in response to retinoids.  
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Chapter 2: 
The Effect of Retinoids on Neuronal Outgrowth from the Novel Floating 
Central Nervous System Preparation 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 
 
2.01 Introduction 
Retinoic acid synthesis and signalling has been shown to be up-regulated following 
injury in several species, such as axolotls (Maden, 1982; 1983), newts (Viviano et. al., 1995), 
and following sciatic nerve crush injury in adult rats (Zhelyaznik et. al., 2003). Moreover, 
disruption of the retinoic acid pathway has been shown to disrupt regeneration in numerous 
species (Maden et. al., 1982; Dmetrichuk et. al., 2005). Retinoic acid has also been found to 
induce and enhance neurite outgrowth in various model systems including newt spinal cord 
explants (Dmetrichuk et. al., 2005) and in Lymnaea stagnalis (Dmetrichuk et. al., 2006). 
Retinoic acid has also been shown to be involved in directed neurite outgrowth from 
regenerating cultured cells (Prince and Carlone, 2003; Dmetrichuk et. al., 2005). Altogether, 
these findings have suggested a crucial role for retinoic acid in neural regeneration.   
Two biologically active isomers of retinoic acid are all-trans retinoic acid and 9-cis 
retinoic acid. Some studies have suggested that these two isomers act in a similar manner. 
Pedersen et. al. (1995) identified that both isomers increased the choline acetyltransferase 
activity and the intracellular levels of acetylcholine in a murine septal cell line. All-trans and 
9-cis retinoic acid also induced similar inhibition of proliferation of human neuroblastoma 
cells (Plum and Clagett-Dame, 1995). On the other hand, other studies have demonstrated 
that all-trans and 9-cis retinoic acid may also act differently. In a study conducted by Han et. 
al. (1995), 9-cis retinoic acid was found to be more potent than all-trans retinoic acid in its 
antiproliferative and differentiation activity in human neuroblastoma cells, and both isomers 
were found to exert contrary effects on the production of extracellular matrix proteins and the 
proliferation of activated hepatic stellate cells from rats (Hellemans et. al., 1999). Similarly, 
in Lymnaea stagnalis, all-trans and 9-cis retinoic acid can have differing effects on the 
electric properties and intracellular calcium levels of cultured neurons. In particular, all-trans 
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retinoic acid was found to be more potent in inducing abnormal firing and reducing 
intracellular calcium levels than 9-cis retinoic acid (Vesprini and Spencer, 2014; Vesprini et. 
al., 2015). However, both of these isomers can induce neurite outgrowth from cultured 
Lymnaea neurons (to a similar extent), and both isomers can induce growth cone turning 
(Dmetrichuk et. al., 2006; 2008). These culture studies thus suggest that all-trans and 9-cis 
retinoic acid exert similar neurotrophic and tropic effects in the mollusc Lymnaea.  
Previous research suggested that growth cone migration and axon elongation relies on 
adhesive contacts with solid substrates (Gomez and Letourneau, 2014). However, a novel 
phenomenon has been identified since, in which neurite outgrowth can be observed from the 
Lymnaea CNS “floating” on the surface of Defined Medium, i.e. in the absence of substrate 
adhesion. Moreover, neurites from the Lymnaea CNS have been found to grow towards 
floating nerve fragments in their vicinity, suggesting these growth cones may be capable of 
axon guidance in the absence of a (solid) substrate adhesion.  
The main aim of this study was to examine the feasibility of this newly identified 
model system to investigate the effects of retinoic acid on regeneration in Lymnaea. In 
particular, we sought to determine whether all-trans and 9-cis retinoid isomers could induce 
neurite outgrowth from these CNS, and if so, whether the two retinoid isomers exerted 
similar (or differing) effects. We also aimed to determine whether growth cones of these 
floating neurites could demonstrate a chemotropic response to retinoic acid.  
Based on previous findings from cultured Lymnaea nerve cells, we hypothesized that 
the retinoid isomers would enhance neurite outgrowth from the floating CNS in a similar 
manner. Furthermore, we hypothesized that growth cones at the tip of these floating neurites 
would be capable of sensing guidance cues and thus turn towards a local source of retinoic 
acid, in the absence of substrate adhesion.   
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2.02 Materials and Methods 
Animals: 
The pond snails, Lymnaea stagnalis, were reared and housed in open air tanks 
containing aerated water (with Instant Ocean Sea Salt added, (measurement 6g/L)) and were 
fed with romaine lettuce daily and fish food (Nutrafin Max Spirulina Algae Flake Food) and 
carrots twice a week. All animals used ranged in size from 16 to 20 mm in length. 
Chemicals: 
The retinoids all-trans (atRA) and 9-cis retinoic acid (9-cis RA) were obtained from 
Sigma-Aldrich and dissolved in dimethyl sulfoxide (DMSO) and diluted in the culture dishes 
containing the ‘floating’ whole CNS to produce a final bath concentration of either 10-6M or 
5 x 10
-7
M. Equivalent concentrations of DMSO added (vehicle control experiments) were 
0.01% and 0.005% respectively. These retinoid concentrations were chosen as both 
concentrations have previously been used to examine outgrowth from the floating CNS 
(Racey, 2015) and  5 x 10
-7
M  is the estimated endogenous concentration of retinoids within 
the Lymnaea CNS (Dmetrichuk et al 2008).  
Floating CNS Preparation:  
Lymnaea stagnalis were anaesthetized (25% Listerine in saline) and their CNS were 
removed. The CNS were passed through a series of three 5 minute antibiotic saline washes 
(ABS; antibiotic saline: Lymnaea saline containing 225 μg/mL gentamicin (Sigma-Aldrich)). 
Next, the CNS were pinned down in ABS and the outer connective tissue was removed 
(Figure 6).  Preliminary trials that were conducted suggested that optimal outgrowth was 
observed when three CNS were placed per dish. Thus, three CNS were placed on the surface 
of 3 ml of DM in each dish (Falcon Easy Grip Petri dishes, 35x10mm). DM consists of 50% 
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L-15 (Leibowitz) media, 4X salts (NaCl 40mM, KCl 1.7mM, CaCl2 4.1mM, MgCl2 1.5mM 
and HEPES 10mM), Glutamine (60mg/L), D-Glucose (6mg/L), Gentamicin (25μg/mL), and 
autoclaved distilled water (24.6%); pH of 7.9. 
 
Figure 6. Lymnaea CNS. The Lymnaea CNS extracted and pinned out in a dissection dish in ABS. 
Scale bar: 1mm. 
 
To analyze the trophic effect of atRA and 9-cis RA to induce neurite outgrowth, 
either retinoid or the vehicle (DMSO) were added into the culture dishes containing the 
floating CNS. Preliminary (unpublished) studies from our laboratory have demonstrated that 
floating Lymnaea CNS placed in a 3% ambient oxygen level exhibit more neurite outgrowth 
than at a 20% ambient oxygen level. All experiments (experimental and control) were 
therefore carried out in a 3% controlled oxygen environment to obtain maximal neurite 
outgrowth across the dishes. Regulation of the ambient oxygen levels was achieved using an 
oxygen regulator (Sable Systems International) kindly provided by G. Tattersall. 
 
Growth Cone Turning Assays: 
As described above, three Lymnaea CNS were extracted and placed on the surface of 
DM. Approximately 16 to 18 hours following plating, growth cones could be observed at the 
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tips of neurites extending from the floating CNS. All-trans retinoic acid was prepared in 
absolute ethanol (EtOH; Sigma-Aldrich) and diluted to a final concentration of 10
-5
M using 
DM (0.1% final EtOH concentration). All-trans retinoic acid was pressure-applied onto the 
growth cones through a pipette, using a Femtojet microinjector (Eppendorf, Canada). The 
pipette was placed between 400 to 500μm from the growth cone, depending on both the size 
of the pipette opening (range= 8-10μm) and the pressure applied. A holding pressure of 1-
2hPa was used to prevent backflow into the pipette between applications. Growth cone 
movement was monitored and photographed throughout, using Northern Eclipse imaging 
software (Empix imaging, ON). Images were taken every 4-5 minutes over the course of each 
growth cone turning assay. Due to the slow response and sensitive nature of floating growth 
cones, no vehicle control experiments were conducted at this time, though numerous 
published findings from our lab have established that application of the vehicle alone does 
not induce positive growth cone turning (Dmetrichuk et. al., 2006; 2008; Farrar et. al., 2009; 
Rand, 2012; Rand et. al., 2017). 
 
Data and Statistical Analysis:  
All images were captured using an inverted Zeiss Axiovert 200 microscope, Retiga 
Exi camera and Northern Eclipse software (Empix Imaging Inc.). Neurite outgrowth was 
assessed approximately 72 hours following plating. The proportion (%) of floating nerves 
that exhibited neurite outgrowth in the presence of DMSO, 9-cis RA, and atRA in the bath 
was determined.  Only floating nerves were counted, as those submerged do not exhibit 
outgrowth. A Chi-square test was used to determine significance. In order to determine if 
retinoids enhanced the length of neurites, the average of the three longest neurite processes 
per cut nerve was determined for only nerves that exhibited outgrowth. The mean length of 
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the neurites was then determined in each of the three conditions: DMSO, 9-cis RA, and 
atRA. Values were compared using a Kruskal-Wallis One Way ANOVA on Ranks, and a 
Dunn’s post hoc test was used to determine statistical significance. Data were deemed 
significant when p<0.05.  
In order to determine whether retinoids induced more outgrowth (density), the cut 
nerve ending with the densest neurite outgrowth from each CNS was selected and the growth 
coverage of a defined area was analyzed. Preliminary observations indicated that in all three 
conditions (DMSO, 9-cis RA, and atRA) neurites usually grew up to a length of at least 
200µm from the cut nerve endings. No previous recordings of outgrowth density have been 
made, and as such, an arbitrary circular area with a diameter slightly greater than 200µm 
(207.8µm) was chosen to analyze neurite coverage. This circular area was identical in size 
for each measurement. It was drawn in ImageJ and placed at the cut nerve endings, such that 
the center of the circle aligned with the center of the cut nerve ending (Figure 7). The neurite 
outgrowth was highlighted in ImageJ and the proportion (%) of space occupied by this 
neurite outgrowth (neurite coverage) within the defined area (135620 μm2) was determined 
(Figure 7 and Appendix 5). Values for neurite coverage in all conditions DMSO, 9-cis RA, 
and atRA were compared using a Kruskal-Wallis One Way ANOVA on Ranks, and a Dunn’s 
post hoc test was used to determine statistical significance. Data were deemed significant 
when p<0.05.  
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Figure 7. Analysis of the proportion of neurite outgrowth coverage within a defined area. 
Representative images of neurite outgrowth from a cut nerve ending of a Lymnaea CNS “floating” on 
the surface of DM (A). The proportion (%) of neurite outgrowth coverage was determined within a 
defined area of 135620 μm2 (indicated by circle) from the cut nerve ending using ImageJ software, as 
demonstrated in B. The dashed arrows indicate aligning the center of the circle to the center of the cut 
ending (B). Scale bar= 60μm (A).    
 
For the growth cone turning assays, the individual growth cone turning angles were 
determined by measuring the angle between the growth cone's initial trajectory and the final 
angle of turning observed over the course of the experiment (Figure 8). Growth cones were 
monitored for a minimum of 1 hour (as done previously in cultured neurons; Farrar et. al., 
2009; Carter et. al., 2010) to a maximum of 4 hours (additional time was required as neurites 
appeared to grow slower than in cultured neurons moving on a substrate). An attractive 
turning response consisted of the growth cone turning towards the pipette and was deemed as 
a positive angle.  
 
 
 
A) B) 
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A. t= 0                                                          B. t= 240 
 
Figure 8. Measurement of the turning angle of floating growth cones in response to atRA.      
(A) Representative image of floating growth cones extending from a Lymnaea CNS. The black arrow 
points to the growth cone analyzed in this figure. The red line at the top of the image and the dashed 
white line indicate the growth cone’s initial trajectory, before locally applying atRA.     (B) The 
floating growth cone’s turning response to a local source of atRA (indicated by a pipette on the right 
side of the image) was measured. The initial trajectory of the growth cone, marked in (A), was 
superimposed onto the final recorded image of the growth cone turn (B). The red line indicates no 
change in the angle of the neurite near the cut nerve ending. The dashed white line indicates a slight 
change in the angle of the neurite immediately preceding the growth cone studied, and this has also 
been observed in growth cone studies performed in cell culture. The dotted white arrow indicates the 
final turning response recorded for the growth cone. The asterisk represents the angle measured as the 
turning response for this growth cone. Times are given in minutes. Scale bar = 25μm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
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2.03 Results 
The Effect of Retinoids on Neurite Outgrowth  
In Lymnaea stagnalis, it has been demonstrated that atRA and 9-cis RA induce 
similar trophic effects on cultured nerve cells (Dmetrichuk et. al., 2006; 2008). However, a 
difference in the effects of these retinoid isomers has been observed when examining the 
electric properties and intracellular calcium levels of cultured Lymnaea neurons (Vesprini 
and Spencer, 2014; Vesprini et. al., 2015). Since our lab has recently determined that neurite 
outgrowth can be observed from the Lymnaea CNS placed on the surface of DM, we sought 
to investigate the effects of these retinoid isomers on the extent of neurite outgrowth and to 
determine whether the effects would be similar between atRA and 9-cis RA isomers. 
The extent of neurite outgrowth from floating Lymnaea CNS, in higher (10
-6
M) and 
lower (5x10
-7
M) concentrations of retinoids and equivalent concentrations of DMSO (0.01% 
and 0.005%, respectively) was analyzed. Representative images depicting neurite outgrowth 
observed from cut nerve endings of Lymnaea CNS floating on the surface of DM with 
DMSO, 9-cis RA, or atRA in the bath are shown in Figure 9. The proportion (%) of floating 
nerves that exhibited outgrowth of neurites after 72 hours in each treatment was determined 
and a Chi-square test showed no significant effect of treatment at higher concentrations of 
retinoids  (10
-6
M: Chi-square= 0.48, df=2; p = 0.787; Figure 10 A). However, at lower 
concentrations (5x10
-7
M), a significant effect of treatment was observed (Chi-square= 
13.705, df= 2; p = 0.001). The proportion of floating nerves that exhibited outgrowth was 
significantly less in atRA compared to both 9-cis RA (p=0.004) and DMSO (p=0.006; Figure 
10 B).   
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A) DMSO 
      
B) 9-cis RA 
       
C) atRA 
       
Figure 9. Neuronal outgrowth from floating CNS in DMSO, 9-cis RA, and atRA. Two 
different representative images for each treatment, taken at 72 hours, depicting the variation in 
the extent of neurite outgrowth observed from cut nerve endings emerging from floating 
Lymnaea CNS in: (A) DMSO, (B) 9-cis RA, or (C) atRA. Scale bars= 60 μm. 
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Figure 10. Fewer nerves exhibit neurite outgrowth in atRA at lower concentrations. 
Summary graphs showing the proportion of floating nerves that exhibited outgrowth after 72 
hours in the presence of 9-cis RA and atRA at a concentration of 10-6M (A) and 5x10-7M (B), and 
equivalent concentrations of the vehicle DMSO (0.01% (A) and 0.005% (B), respectively). 
Statistical analysis used a Chi-square test and determined that at higher concentrations of 10-6M , 
there was no significant effect of treatment (Chi-square= 0.48, df=2; p = 0.787). However, at 
lower concentrations of 5x10-7M, a significant effect of treatment was observed (Chi-square= 
13.705, df= 2; p = 0.001). The proportion of floating nerves that exhibited outgrowth was 
significantly less in atRA compared to both 9-cis RA (*p=0.004) and DMSO (#p=0.006). N 
values for each treatment are provided in brackets and represent the total number of floating 
nerves analyzed (including floating nerves that did not exhibit outgrowth). 
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The maximal length of outgrowth from all cut nerves exhibiting outgrowth in each 
treatment was also determined. A Kruskal-Wallis One Way ANOVA on Ranks found no 
significant difference in the maximal length of neurites in each treatment at both higher 
concentrations of retinoids (10
-6
M: H = 0.585, df=2; p= 0.746; Figure 11 A) and lower 
concentrations (5x10
-7
M: H = 3.345, df=2; p=0.188; Figure 11 B). All three treatments 
produced neurites of equivalent lengths.  
For the above two parameters measured, more than one cut nerve emanating from one 
CNS was analyzed. This gave rise to the consideration that the extent of neurite outgrowth 
from one individual cut nerve might depend on which CNS it originated from, and may be 
influenced by other nerves emanating from the same CNS. Though it is currently unknown 
whether the outgrowth from one nerve can directly affect the outgrowth from another, the 
proportion (%) of floating nerves that exhibited neurite outgrowth and the maximal length of 
outgrowth observed were therefore re-analyzed keeping the “identity” of the nerve (which 
CNS it emerged from), a consideration in the analysis. These additional data, analyzed using 
R software (© The R Foundation), are presented in the appendix (Appendix 1 and 2). Overall, 
the findings of these additional analyses were similar to those mentioned above (which 
assumed independence of all observations). 
 
 
 
 
 
36 
 
 
 
 
 
           
                      DMSO        9-cis RA       atRA                     DMSO        9-cis RA        atRA     
 
 
 
Figure 11. Retinoids do not increase the mean length of neurite outgrowth. Summary graphs 
showing the maximal length of neurite outgrowth observed in 9-cis RA and atRA at a 
concentration of 10-6M (A) and 5x10-7M (B), and in DMSO (at equivalent concentrations of 
0.01% (A) and 0.005% (B), respectively). Error bars represent the standard error of the mean 
(S.E.M.). Statistical analysis was performed using a Kruskal-Wallis One Way ANOVA on 
Ranks.  No significant difference was found amongst treatments, at higher (10-6M: H = 0.585, 
df=2; p= 0.746) or lower concentrations (5x10-7M: H = 3.345, df=2; p=0.188). N values for each 
treatment are provided in brackets and represent the total number of nerves analyzed. Only 
nerves that exhibited outgrowth were analyzed. 
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Though the retinoid treatments did not induce longer neurite outgrowth, it was possible 
that they affected the “density” of outgrowth emerging from the cut nerves. The proportion 
(%) of space covered by neurite outgrowth within a defined area was thus also determined.  
A Kruskal-Wallis One Way ANOVA on Ranks found no significant difference in the neurite 
coverage of the defined area between vehicle control treatment and retinoids at the higher 
concentration (10
-6
M: H = 0.645, df=2; p = 0.724; Figure 12 A). However, at lower retinoid 
concentrations (5x10
-7
M), a significant effect of treatment was observed (H= 9.456, df= 2; 
p=0.05). A Dunn’s post-hoc test revealed that a significantly higher neurite coverage of the 
defined area occurred in the presence of 9-cis RA compared to atRA (p=0.009; Figure 12 B).  
Overall, these data indicate that at lower concentrations (5x10
-7
M), 9-cis RA appeared to 
promote more outgrowth from the Lymnaea CNS, than atRA. These effects, however, were 
not replicated at higher concentrations (10
-6
M), where there was no significant effect of 
retinoids on the extent of neurite outgrowth from the Lymnaea CNS. 
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Figure 12. 9-cis RA induces more neurite coverage than atRA. Summary graph showing the 
mean neurite coverage (% of a defined area) in the presence of 9-cis RA and atRA at a 
concentration of 10-6M (A) and 5x10-7M (B), and in DMSO (at equivalent concentrations of 
0.01% (A) and 0.005% (B), respectively). Error bars represent the standard error of the mean 
(S.E.M.). The cut nerve ending with the “densest” neurite outgrowth on each CNS was selected 
for growth analysis. A Kruskal-Wallis One Way ANOVA on Ranks determined that at higher 
concentrations there was a no significant effect of treatment (10-6M: H = 0.645, df=2; p = 0.724). 
However, at lower concentrations, a significant effect of treatment was observed (5x10-7M: H= 
9.456, df=2; p=0.05) and a Dunn’s post-hoc test determined that 9-cis RA induced significantly 
higher neurite coverage than atRA (*p=0.009). N values for each treatment are provided in 
brackets and represent the total number of nerves analyzed.  
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atRA Induced Growth Cone Turning of Floating Neurites 
Whilst examining neurite outgrowth from floating CNS, it was noted that neurites 
occasionally grew towards floating nerve fragments found in their vicinity, suggesting that 
they are capable of sensing and responding to chemotropic guidance cues. Previous findings 
have determined that retinoic acid can induce a chemotropic effect on growth cones of 
cultured Lymnaea cells (Dmetrichuk et. al., 2006; 2008). We therefore conducted a pilot 
study to determine whether growth cones on these floating neurites could indeed sense 
chemical guidance cues, by testing whether they would turn towards a local source of 
retinoic acid. A local gradient of atRA (10
-5 
M) was focally applied onto growth cones at the 
tips of floating neurite processes. The growth cones were found to turn toward the source 
(pipette) of retinoic acid with a mean turning angle of 25.3 ± 6.5° (n=9; Figure 13 A-D). A 
graph showing the final turning angle of each individual growth cone in response to atRA is 
shown in Figure 13 E. Individual growth cone turns toward atRA are depicted as a positive 
turning angle in the graphs. Overall, the data from these pilot studies support the hypothesis 
that the floating growth cones (in the absence of solid substrate adhesion) are capable of 
responding to guidance cues.   
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atRA 
A. t= 0                                                       B. t= 60 
 
             C. t=120                                                       D. t=240 
 
E. 
  
Figure 13. Floating growth cones are attracted to a gradient of atRA. (A-D) Representative 
images depicting the turning responses of growth cones (indicated by arrows) to a local gradient 
of atRA. The pipette tip is shown in the lower right hand corner. E. A graph showing the 
individual final turning angles toward atRA with each bar representing one growth cone (n=9). 
Times are given in minutes. Scale bar = 25μm. 
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2.04 Discussion 
The Effect of Retinoids on Neuronal Outgrowth from the Novel CNS Preparation 
It has generally been established that neurite outgrowth and growth cone motility are 
dependent on the adhesion of cells to a solid substrate (Suter and Forscher, 2000; Koch et. 
al., 2012). However, our lab has recently shown that neurite outgrowth can also occur from 
Lymnaea CNS floating on the surface of DM (J. Simmons, unpublished findings). Since only 
cut nerves of the Lymnaea CNS that were floating exhibited neurite outgrowth, we had 
initially speculated that increased levels of ambient oxygen at the surface may play a role in 
the induction of this outgrowth. However, previous studies conducted by D. Britt, G. 
Tattersall, and G. Spencer (unpublished findings) showed a greater extent of outgrowth from 
floating nerves of the Lymnaea CNS at lower ambient oxygen levels (e.g. 3% and 5% oxygen 
levels compared to 20%), suggesting that increased oxygen levels are not responsible for this 
outgrowth. Another possibility that we have not yet examined is that surface tension of the 
fluid plays a role in inducing outgrowth. Although we are still unsure of the mechanism by 
which the floating cut nerves of the intact Lymnaea CNS exhibit this increased neurite 
outgrowth, this new model could prove promising to study the regenerative behaviour of 
invertebrate neurons, as the neurite outgrowth is easily monitored and measured over time.  
One molecule that has been implicated in regeneration in both vertebrates and 
invertebrates is retinoic acid. For example, a role for retinoic acid in inducing and enhancing 
neurite outgrowth has been shown in newt spinal cord tissue (Dmetrichuk et al., 2005) and 
embryonic chick dorsal root ganglia neurons (Maden et. al., 1998). Previous studies in 
Lymnaea have shown that the retinoid isomers 9-cis RA and atRA induce similar trophic 
effects on neurite outgrowth from cultured motorneurons (Dmetrichuk 2006; 2008). 
Moreover, 9-cis RA and atRA were both shown to induce positive turning of Lymnaea 
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growth cones in culture (Dmetrichuk et al., 2006; 2008). Consequently, my main aim was to 
determine the effect of these retinoid isomers on the extent of neurite outgrowth and the 
growth cone turning behaviour of floating neurites, emerging from floating CNS. 
Preliminary studies using this preparation have previously found no significant 
increase in the extent of neurite outgrowth from the floating CNS in the presence of atRA, 
compared to the vehicle DMSO (Karolak, 2014). However, the floating CNS were only 
treated to lower concentrations of atRA (5x10
-7 
M) and the threshold concentration needed to 
see an effect may have been higher. On the other hand, some significant effects were 
previously shown for 9-cis RA at a higher concentration of 10
-6 
M, compared to the vehicle 
DMSO (Racey, 2015). These effects included an increase in the proportion of nerves 
exhibiting neurite outgrowth and an increase in the length of outgrowth at some timepoints 
(but not at others).  
In an attempt to resolve the ambiguity of the preliminary results previously obtained, 
my first aim was to directly compare the effects of the two retinoid isomers, atRA and 9-cis 
RA, under similar conditions and at the same time points. My data suggested an ability of 9-
cis RA to enhance neurite outgrowth but the effects were not consistent across different 
concentrations tested. However, it was apparent that 9-cis RA was more likely to enhance 
neurite outgrowth compared to atRA, and these findings were consistent with preliminary 
data obtained by Karolak (2014) and Racey (2015). It is unclear why 9-cis RA showed 
significant differences to atRA at only the lower concentration, but one possibility is that 
effect of the retinoid isomers on the extent of neurite outgrowth may have been compounded 
by negative effects of the vehicle (DMSO) at higher concentrations. At the higher 
concentrations of DMSO (0.01%), my data showed a reduction in the proportion (%) of 
floating nerves that exhibited outgrowth, the maximal length of outgrowth, and the “density” 
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of outgrowth, compared to lower concentrations of DMSO (0.005%). If neurite outgrowth is 
dependent on surface tension, it is feasible that DMSO may have altered this property and 
ultimately interfered with the ability of the nerves to exhibit outgrowth. However, further 
research will be needed to test this hypothesis, as well as to more closely examine possible 
differences between the two retinoid isomers.  
Until now, previous findings have been unable to demonstrate that retinoic acid 
consistently enhances neurite outgrowth from the floating Lymnaea CNS. One possible 
reason for this might be that the CNS is secreting other trophic factors, whose effects may be 
manifested to a greater extent than those of exogenously applied retinoic acid, thus masking 
its effects. Indeed, previous studies in Helisoma support the notion that trophic factors are 
released from the isolated CNS (Wong et. al., 1981). This possibility might help explain the 
lack of significant effects of the retinoid isomers on the length of neurite outgrowth from the 
CNS, compared to the vehicle. These data also appear contrary to the neurite-inducing effects 
previously observed by the two isomers on cultured neurons. However, it should be noted 
that previous studies examined the effects of the retinoids on cultured Lymnaea neurons in 
the absence of any other trophic factors (Dmetrichuk et. al., 2008).  
A lack of a consistent effect of retinoic acid in enhancing neurite outgrowth from the 
floating CNS may also be due to increased metabolism of retinoic acid by the CNS 
(compared to the metabolism of retinoic acid by a small number of individual neurons in 
culture). It is very likely that the retinoic acid was degraded or metabolised much faster by 
the CNS than by cultured neurons (Christie et. al., 2008). In the floating CNS experiments, 
the retinoic acid was added only once, on the first day, to a dish containing three floating 
CNS which would likely metabolize retinoic acid relatively quickly, thereby reducing its 
trophic effects. This would not occur to the same extent with cultured cells. Any further 
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research that intends to continue examining the effects of retinoids on neurite outgrowth from 
the floating CNS will likely need to refine the experimental protocols in order to obtain more 
consistent effects.  
Nonetheless, the results found in my study are intriguing as they suggest that retinoid 
isomers may induce different effects on neurite outgrowth from the floating Lymnaea CNS. 
This differs to what was previously observed in cultured Lymnaea neurons where it was 
previously shown that 9-cis RA and atRA exerted similar trophic effects (Dmetrichuk 2006; 
2008). However, it should be noted that not all effects of these retinoids are similar in 
Lymnaea, as previous studies have also shown different effects of all-trans and 9-cis RA on 
their ability to change both firing properties and intracellular calcium levels (Vesprini and 
Spencer, 2014; Vesprini et. al., 2015). Since neuronal activity and intracellular calcium are 
well known to affect both gene transcription and neurite outgrowth, it is quite possible that 
these cellular properties may be involved in the differing effects of the isomers seen in this 
study.  
 
The Effect of atRA on the Growth Cone Turning Behaviour of Floating Neurites 
 In addition to examining the effect of retinoid isomers on the extent of neurite 
outgrowth on the floating CNS, we also sought to investigate the growth cone turning 
behaviour of these floating neurites. Previous research suggested that growth cone migration 
and axon elongation relies on adhesive contact with a solid substrate in order to occur 
(Gomez and Letourneau, 2014). However, we have clearly demonstrated that neurite 
outgrowth can also occur from floating Lymnaea CNS in the absence of any adhesive 
contacts with a solid substrate. Anecdotal evidence and observations from previous 
preliminary studies in the lab have also suggested that these floating neurites can grow 
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towards neighboring floating nerve fragments. This gives rise to the possibility that growth 
cones on these floating neurites might be able to sense and respond to guidance cues in the 
absence of (solid) substrate adhesion.  
My second aim was thus to conduct a pilot study to investigate whether the floating 
growth cones could respond to a guidance cue, and indeed demonstrated that the growth 
cones responded by turning toward a focal source of atRA. However, both neurite extension 
and growth cone turning was found to occur very slowly in these floating preparations; in 
most instances, it took between 1 and 4 hours to obtain growth cone turning responses. It is 
possible that the growth cone response occurred more slowly (than that of cultured growth 
cones), either as a result of the slower rate of outgrowth or due to the absence of a solid 
substrate. Indeed, previous studies have suggested that the speed of growth cone 
advancement might rely on the strength of adhesiveness to a substrate (Letourneau, 1975; 
Gomez and Letourneau, 2014). Moreover, the floating growth cones were found to be 
extremely sensitive to agitation of the surface of the solution (such as occurred by the 
insertion of the pipette and occasionally during application of the retinoic acid). However, 
this might further support a role for surface tension in the outgrowth from these floating 
CNS.  
As a result of the increased “sensitivity” of the growth cones, we determined that this 
preparation was likely not a feasible model system for further examination of the 
chemotropic effects of retinoic acid (or for further elucidation of the transduction pathways 
involved in growth cone turning responses). Furthermore, due to the slow response and 
sensitive nature of the floating growth cones, no vehicle control experiments were conducted 
at this time. However, it should be noted that previous findings from our lab have 
consistently shown that application of any vehicle (either EtOH or DMSO) does not induce 
46 
 
any positive growth cone turning (Dmetrichuk et. al., 2006; 2008; Farrar et. al., 2009; Carter 
et. al., 2010; 2015; Rand, 2012; Rand et. al., 2017). However, these findings were in cultured 
neurons and so we cannot completely rule out the possibility (though unlikely) that vehicle 
application would also have no effects on the floating growth cones.  
Nonetheless, these experiments have provided the first preliminary evidence for a 
chemotropic response of floating neurites in the absence of solid substrate adhesion and 
further support a physiological role for atRA in axonal pathfinding. Moreover, the tropic 
effects of retinoic acid were only previously shown using Lymnaea motorneurons (PeA and 
Visceral F), but data here suggest that the other cell types may also be responsive to atRA. 
Overall, in summary, a novel phenomenon has been identified in our lab in which 
neurite outgrowth can be observed from Lymnaea CNS floating on the surface of defined 
(culture) medium. Unlike previous findings from Lymnaea cells in culture, there was a lack 
of a consistent effect of retinoid isomers in promoting neurite outgrowth from the floating 
CNS. Interestingly however, findings may suggest a greater potential for 9-cis RA to enhance 
neurite outgrowth than atRA, but, further research will be required to verify this. 
Nonetheless, atRA was still able to induce a chemotropic response from growth cones of 
these floating neurites, in the absence of substrate adhesion. This novel finding demonstrates 
that, unlike previously believed, growth cones can still sense and respond to guidance cues 
(at least retinoic acid) in the absence of substrate adhesion. 
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Chapter 3: 
An Investigation of the Cellular Mechanisms Involved in Retinoic-acid 
Mediated Growth Cone Turning 
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3.01 Introduction 
Retinoic acid has been implicated in the development (Chen and Solursh, 1992; 1994) 
and regeneration of various organ systems in several species (Tsonis et. al., 2002; Maden and 
Hind, 2003). This includes the nervous system (Maden, 1996; 1998; Dmetrichuk et. al., 
2005), where it can exert trophic effects to initiate and maintain neurite outgrowth (Corcoran 
et. al., 2002; Prince and Carlone, 2003; Dmetrichuk et. al., 2005). The main effects of 
retinoic acid are thought to occur via signalling through nuclear receptors, which include 
retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which then regulate gene 
transcription. RARs and RXRs have different binding affinities for different retinoid isomers 
(Heyman et. al., 1992; Allenby et. al., 1994), but these binding affinities appear to differ 
between vertebrates and invertebrates (Nowickyj et. al., 2008). In the mollusc Lymnaea, both 
RXR (LymRXR) and the putative RAR (LymRAR) have been cloned (Carter et. al., 2010; 
2015), but their binding affinities and/or their ability to heterodimerize are not yet known. In 
addition to transcriptional activity of retinoic acid via its nuclear receptors, nongenomic 
effects of retinoic acid have also been described, such as regulation of homeostatic plasticity 
in the vertebrate hippocampus (Aoto et. al., 2008; Maghsoodi et. al., 2008). 
Nongenomic effects of retinoic acid have also been found to underlie chemotropic 
effects of retinoids to induce growth cone turning in Lymnaea neurons (Farrar et. al., 2009). 
Retinoic acid acts as a chemoattractant for vertebrate spinal cord neurons (Maden et. al., 
1996; 1998; Dmetrichuk et. al., 2005) as well as invertebrate motorneurons (Dmetrichuk et. 
al., 2006; 2008; Farrar et. al., 2009; Rand, 2012). In Lymnaea, growth cones mechanically 
isolated from their cell bodies have been found to retain their capacity to respond to, and turn 
toward retinoic acid (Farrar et. al., 2009). Studies in Lymnaea have previously shown 
LymRXR is present in the growth cones of cultured regenerating motorneurons (Carter et. al., 
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2010). Furthermore, a RXR agonist, PA024, was able to induce growth cone turning in both 
intact and isolated neurites (Carter et. al., 2010).  Carter et. al. (2015) also recently identified 
a non-nuclear distribution for the LymRAR in growth cones, though no studies to date have 
shown whether RAR agonists can mimic the chemoattractive effects of retinoic acid. In this 
study, we thus aimed to determine whether various RAR agonists and synthetic retinoids 
could mimic the effects of retinoic acid to produce growth cone turning in cultured 
regenerating Lymnaea neurons. Although the RXR agonist, PA024, was previously tested 
and found to induce growth cone turning in Lymnaea, this agonist is no longer available for 
use. Since there has also been limited study of this receptor to date, an alternative 
(commercially available) RXR agonist, SR11237, was tested to determine whether it would 
induce growth cone turning.  
Although previous studies have provided some evidence for the role of neuritically 
localized retinoid receptors in the chemoattractive effects of retinoic acid, far less is known 
of other potential signalling components involved in this response. To date, retinoic acid-
mediated growth cone turning has been shown to require both local protein synthesis and 
calcium influx (Farrar et. al., 2009). However, the signalling cascades which link the calcium 
influx to regulation of the cytoskeleton are not currently known. A possible link might be the 
activation of Rho GTPases, which include Ras-related C3 (Rac). Rho GTPase signalling 
occurs downstream of activation of the growth cone membrane receptors and calcium 
signals, and upstream of effectors of cytoskeletal dynamics. Rho GTPases have been shown 
to mediate growth cone responses to a number of guidance cues in the nervous system (Yuan 
et. al., 2002). In particular, Rac mediates growth cone attraction to netrin in mice (Li et. al., 
2002), and to brain-derived neurotrophic factor (BDNF) in Xenopus laevis (Yuan et. al., 
2003). However, whether Rho GTPases play a role in retinoic acid-induced chemoattraction 
50 
 
has not yet been studied. The aim of this study was thus to determine whether the Rho 
GTPase Rac is involved in retinoic acid-mediated growth cone turning in regenerating 
Lymnaea neurons.  
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3.02 Materials and Methods 
Animals: 
The pond snails, Lymnaea stagnalis, were reared and housed in open air tanks containing 
aerated filtered water. Water was supplemented with salts (Instant Ocean Sea Salt) at a 
concentration of 6g/L. They were fed romaine lettuce daily, and fish food (Nutrafin Max 
Spirulina Algae Flake Food) and carrot shavings twice a week. All animals used for cell 
culture experiments ranged in size from 16 to 20 mm in length. 
Preparation of Poly-l-Lysine Coated Culture Dishes and Lymnaea Conditioned Medium 
(CM):  
Cell culture dishes (Falcon Easy Grip Petri dishes, 35x10mm) were prepared by drilling a 
hole (1cm in diameter) through the bottom of the dish. A glass cover slip was attached to 
each dish below the drilled hole and the plates were sterilized with 95% ethanol (EtOH). 
Once dry, the dishes were coated overnight with poly L lysine (1mg/mL Tris buffer). The 
following morning, a glass pipette was used to remove the poly L lysine and the dishes were 
left to dry for 40 minutes. The dishes were then washed three times (15 minutes each) with 
distilled water and left to dry. These poly L lysine coated culture dishes were stored between 
+2 and 8°C and used within 7 days.    
Lymnaea Conditioned Medium (CM) contains (unidentified) trophic factors that are 
required for generating outgrowth in vitro. CM was prepared by dissecting 12 Lymnaea CNS 
from animals ranging in size from 20-30 mm. These CNS were then passed through a series 
of eighteen washes with antibiotic saline (ABS; sterile saline containing gentamycin at 
225μg/mL), for a duration of seven to ten minutes each. Next, the 12 CNS were placed in 
7.5ml of Defined Medium (DM) in Sigma-coted (Sigma-Aldrich) glass dishes (Pyrex, 
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60x15mm) for incubation. DM consists of 50% L-15 (Leibowitz) media, 4X salts (NaCl 
40mM, KCl 1.7mM, CaCl2 4.1mM, MgCl2 1.5mM and HEPES 10mM), Glutamine 
(60mg/L), D-Glucose (6mg/L), Gentamicin (25μg/mL), and autoclaved distilled water 
(24.6%); pH of 7.9. Following incubation, which lasted 4 days, Lymnaea CNS were again 
passed through a series of eight, seven to ten minute ABS washes, before being transferred to 
a fresh dish of DM for subsequent incubations (2 more in total, each for 3-4 days). CM 
incubated with CNS from the first 4 days was discarded as it is generally thought to contain 
inhibitory factors that do not support neurite outgrowth. CM from the subsequent two 
incubation periods were used to culture neurons and to induce neurite outgrowth.  
Cell Culture Procedures:  
Snails were anaesthetized (25% Listerine® in saline) and their CNS removed. The 
CNS were passed through a series of three 5 minute ABS washes. Next, the CNS were 
treated with trypsin (Sigma-Aldrich; 6mg in 3mL DM) for 19.5 to 22 minutes, followed by 
trypsin inhibitor (Sigma-Aldrich; 6mg in 3mL DM) for 10 minutes. The CNS were then 
pinned out in high osmolarity DM (800μL of 1M Glucose in 30mL DM) and the outer 
connective tissue and inner sheath surrounding the left and right Pedal ganglia were removed.  
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Figure 14. Lymnaea CNS prepared for neuron extraction. The Lymnaea CNS pinned out in a 
dissection dish in preparation for extraction of Pedal A ciliary motorneurons for cell culture. The 
black boxes specify the regions containing the left and right Pedal A motorneurons, as indicated by 
the arrows. Scale bar: 1mm.  
 
Individual Pedal A motorneurons (PeA) were chosen for these studies as they have 
been shown to generate extensive neurite outgrowth in cell culture (Spencer et. al., 1995; 
Dobson et. al., 2006; Farrar et. al., 2009), and have been used in previous growth cone 
studies examining the effects of retinoic acid in Lymnaea (Carter et. al., 2010; 2015). The 
PeA cells were removed from the left and right Pedal ganglia using a fire-polished glass 
pipette coated with Sigmacote (Sigma-Aldrich) to prevent cell adhesion. Suction was applied 
using a micrometer syringe (Gilmont
®
 Instruments, 0.2 mL) to remove individual cell bodies 
from the CNS and these cells were then plated into poly L lysine coated culture dishes 
containing 2.5mL of CM and 0.5mL of DM (Figure 15). All-trans retinoic acid (atRA) was 
added to the culture dishes at the end of cell plating (10
-7
M final bath concentration) to 
promote neurite outgrowth. Extensive outgrowth was observed within 16 to 18 hours 
following plating.  
Left Right 
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Figure 15. Schematic of the cell isolation process and assembly. (A) Neurons were isolated from 
the ganglia by suction via a microsyringe and applied through a glass pipette. The cells were then 
plated, using the micro-manipulator, into culture dishes containing CM (B). Pictures courtesy of Dr. 
Naweed I. Syed (University of Calgary). 
     
Chemicals: 
AtRA was purchased from Sigma Aldrich. The synthetic retinoids: CH55 (which has 
high affinity for vertebrate RAR-α/β receptors), EC23 (an analog of atRA), and SR11237 (a 
selective RXR pan agonist), were obtained from Tocris Bioscience. Refer to Appendix 3 and 
4 for a full description of the synthetic retinoids used in this study. To investigate the effects 
of synthetic retinoids on growth cone turning, atRA and all synthetic retinoids were prepared 
in 100 % dimethyl sulfoxide (DMSO) and diluted using DM to a concentration of 10
-5
M (in a 
final concentration of 0.1% DMSO) and added to the pipette. SR11237 was also tested at      
10
-6 
M (pipette concentration), in order to compare directly with data obtained previously 
with another RXR pan-agonist, PA024 (Carter et. al., 2010). Vehicle control experiments 
used a concentration of 0.1%
 
DMSO (in DM) in the pipette.  
A B 
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The Rac inhibitor, NSC23766, was obtained from Sigma Aldrich. NSC23766 was 
diluted in sterile distilled water and added to the bath at least 1 hour before growth cone 
turning assays, to produce a final bath concentration of 100μM (Hou et. al., 2014).  
Growth Cone Turning Assays: 
Approximately 16 to 18 hours following plating of PeA cells, cells exhibiting neurite 
outgrowth and active growth cones were monitored (Figure 16) and imaged using an inverted 
microscope (Zeiss Axiovert 200).  Only growth cones exhibiting a steady growth trajectory 
for at least 15 minutes were used.  
 
Figure 16. Representative example of PeA neuronal outgrowth in culture. Extensive outgrowth 
can be observed from a cultured PeA neuron after 18 hours of plating. The black arrows indicate 
growth cones at the tips of extending neurites. Scale bar: 60 μm.  
 
Either atRA or synthetic retinoids (CH55, EC23, or SR11237) were pressure-applied 
onto the growth cones via a pipette (4-6μm in diameter, pressure 2-7 hPa), using an 
Eppendorf–Femtojet. The pipette was placed between 50 and 150μm from the growth cone 
(depending on the size of the pipette), and the pressure applied was adjusted accordingly. A 
holding pressure of 1-2hPa was used to prevent backflow into the pipette between 
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applications. In order to test the role of Rho GTPases in atRA-mediated growth cone turning, 
the Rac inhibitor NSC23766 was bath applied. After 1 hour, the active growth cones were 
monitored once again to confirm that the addition of the Rac inhibitor had not disrupted 
neurite outgrowth. Test agents (atRA or EC23) were applied to the growth cones in the 
presence of the Rac inhibitor.  
In order to examine the role of Rac on isolated growth cone responses, the neurites 
were transected from the cell body using a sharp glass electrode (Figure 17). Fifteen minutes 
following isolation, the transected Lymnaea neurites were monitored and growth cones with 
sustained activity were used for growth cone turning assays.  A gradient of atRA (or EC23) 
was applied in a similar manner as described previously for intact neurites. The transected 
neurites were monitored throughout the entire experiment to ensure no contact was re-
established with the cell body (or any adjacent neurites attached to the cell body).  
            
Figure 17. A neurite mechanically isolated from its cell body. (A) An intact neurite connected to 
the cell body. (B) The intact neurite was severed near the cell body. (C) A complete separation of the 
neurite from the cell body. The cell body of the neuron was either completely removed from the dish 
or left in the dish (as in image C) but checked regularly to ensure the neurite remained separated from 
the cell body throughout the experiment. Scale bar: 15μm.  
 
 
A B C 
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Growth Cone Measurements:  
All images were captured using a Zeiss Axiovert 200 inverted microscope and Retiga 
Exi camera with QCapture Suite 2.90.1 software (Quantitative Imaging Corporation). 
Individual growth cone turning angles were determined by measuring the angle between the 
growth cone's initial trajectory and the maximum angle of turning observed over a time 
course of 50 to 60 minutes. Images were taken every 4-5 minutes over the course of each 
growth cone turning assay. An attractive turning response consisted of the growth cone 
turning towards the pipette and is indicated in the data with a positive angle. A negative 
response consisted of the growth cone turning away from the pipette and is indicated in the 
data with a negative angle.  
When examining the effect of the Rho GTPase, the length of neurite extension was also 
measured, using Northern Eclipse imaging software (Empix imaging, ON). Growth cone 
advancement was measured as the distance travelled by the tip of the growth cone at the 
beginning of the assay to its final location at the end of the experiment. An increase in the 
length of the neurite by the end of the experiment produced a positive value whereas neurite 
retraction produced a negative value. 
Data and Statistical Analysis: 
All statistical analyses were performed using SigmaStat software. Growth cone turning 
angles and length of extension measurements induced by each retinoid were expressed as 
mean ± standard error of the mean (S.E.M.). Comparisons of turning angles and length of 
extension measurements for each experiment were performed using a Two Way ANOVA 
with a Holm–Bonferroni Sequential Correction post-hoc test (unless stated otherwise).  
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3.03 Results 
The effects of synthetic retinoids on growth cone turning in the pond snail, Lymnaea 
stagnalis 
We have previously shown the presence of both LymRAR and LymRXR in Lymnaea 
growth cones (Carter et. al., 2010, 2015). However we have only previously shown that one 
synthetic retinoid, the RXR pan agonist PA024, can mimic retinoic-acid induced growth cone 
turning. Unfortunately, this agonist is no longer available for use. Hence, the first aim was to 
examine the effects of various commercially available RAR and RXR agonists on their 
ability to induce growth cone turning in Lymnaea neurons. These studies will provide insight 
into which synthetic agonists most closely mimic the effects of retinoic acid, as well as 
providing further insight into the role of either LymRAR and LymRXR in retinoic-acid 
mediated chemotropic effects.  
Growth cones turn towards a gradient of atRA 
 Before testing the effects of various commercially available retinoid agonists on 
Lymnaea growth cone turning, it was necessary to ensure repeatability of previous findings, 
in that cultured PeA neurites were attracted to a gradient of atRA (Farrar et. al., 2009). Thus, 
a local gradient of atRA (10
-5 
M) was applied to advancing PeA growth cones. Growth cones 
were found to turn toward the source of atRA (contained within the pipette) with a mean 
turning angle of 44.0 + 4.7 ° (n=11; Figure 18 A-B). In contrast, the vehicle (control) did not 
induce growth cone turning toward the pipette (-6.6 + 5.1 °; n=10; Figure 18 D-E).  
Graphical representations of individual growth cone turning values in response to either atRA 
or the vehicle are shown in Figure 18 C and F respectively. Growth cone turning towards 
atRA or the vehicle is depicted as a positive turning angle in the graphs whereas growth cone 
turning away is depicted as a negative turning angle (Figure 18 C, F). 
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atRA                                                                                        
A. t=0                                         B. t=17                                      C.                    
                
 
Vehicle             
D. t=0                                         E. t=30                                      F.                                          
    
 
 
Figure 18. Growth cones are attracted to a gradient of atRA but fail to turn towards the 
vehicle. Representative images depicting the turning response of a PeA growth cone to a local 
gradient of atRA (A-B) or the vehicle (D-E). The pipette tip is shown on the right side of the 
image (B; E). Times (t) are given in minutes. Graphs showing the maximum turning angles 
obtained with atRA (C; n=11) or the vehicle (F; n=10) for each growth cone. Individual growth 
cones are numbered on the y axis of the graphs. Scale bars = 15μm. 
 
 
 
 
Turning Angle (Degrees) 
Turning Angle (Degrees) 
-40 -20 0 20 40 60 80
1
2
3
4
5
6
7
8
9
10
11
-40 -20 0 20 40 60 80
1
2
3
4
5
6
7
8
9
10
60 
 
Growth cones turn towards a gradient of EC23 
After establishing that cultured PeA neurites were attracted to a gradient of atRA (but 
not to the vehicle), we next sought to identify the response of cultured PeA neurites to 
various synthetic retinoids in order to gain more insight into the potential role of LymRAR 
and LymRXR in retinoic acid-mediated growth cone turning. The first synthetic retinoid 
tested was EC23, which is an analog of atRA with a high affinity for RAR (Charton et. al., 
2009). EC23 was tested in order to determine whether it would mimic the chemoattractive 
effects of retinoic acid. A local gradient of EC23 was applied to advancing growth cones at a 
concentration of 10
-5 
M (in pipette). Growth cones were found to turn toward the source of 
EC23 with a mean turning angle of 33.7 + 6.5 ° (n=10; Figure 19 A-B). A graphical 
representation of individual growth cone turning angles in response to EC23 is shown in 
Figure 19 C.  
CH55 induces variable effects on growth cone behaviour 
The second synthetic retinoid tested was CH55, which has high affinity for RAR-α/β 
receptors (Hashimoto et. al., 1990). Variable results on growth cone turning were obtained 
for CH55 (10
-5 
M) (Figure 20). Representative images of a growth cone showing positive 
turning towards the focal source of CH55 are shown in Figure 20 A-B whereas Figure 20 C-
D show a growth cone turning away from the source of CH55.  
A graphical representation of individual growth cone turning angles in response to 
CH55 is shown in Figure 20E. Although there were variable results for this synthetic retinoid 
on individual growth cone turning (Figure 20E), CH55 still induced a mean positive turning 
angle of 15.3 ± 7.7° (n=14).  
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EC23 (Synthetic retinoid and analog of atRA) 
                        A. t= 0                                                 B.  t= 53 
        
 
C.    
 
 
Figure 19. Growth cones are attracted to a gradient of the synthetic retinoid, EC23.          
(A-B) Representative images depicting the turning response of a growth cone to a local gradient 
of EC23. The pipette tip is shown on the right side of the image (B). C. A graph showing the 
individual maximum turning angles toward EC23 (n=10). Times (t) are given in minutes. Scale 
bar = 15μm. 
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CH55 (Synthetic retinoid that has high affinity for RAR-α/β receptors) 
          A. t= 0                                                   B. t= 112 
        
                        C. t= 0                                                  D. t= 30 
        
E.  
 
 
Figure 20. CH55 induces variable effects on growth cone behaviour.  (A-B) Representative 
images depicting the turning response of a growth cone toward a local gradient of CH55. (C-D) 
Representative example of a growth cone turning away from CH55.The pipette tip is shown in 
the upper right hand corner (B; D). E. A graph showing the individual maximum turning angles 
obtained with CH55 (n=14). Times (t) are given in minutes. Scale bars = 15μm. 
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Growth cones turn towards a gradient of SR11237, a selective RXR pan-agonist 
Previous studies from our lab have shown that an RXR pan-agonist, PA024, was able 
to produce growth cone turning in both intact and isolated neurites (Carter et. al., 2010).  
Moreover, the RXR antagonist, HX531, blocked the turning of growth cones towards PA024, 
as well as to both 9-cis and atRA (Rand, 2012). Yet, the precise role of the RXR in growth 
cone turning remains unknown and there has been limited study of this nonchordate receptor 
to date. Unfortunately, the RXR agonist, PA024, is not commercially available and no longer 
available to us. We therefore sought to determine whether a new commercially available 
RXR pan agonist, SR11237, would also mimic RA-induced growth cone turning. If so, this 
would allow us to continue to study the role of RXR in growth cone turning behaviour.  
SR11237 was applied to advancing growth cones at either 10
-5 
M or 10
-6 
M 
concentrations (similar to those used previously for PA024; Carter et. al., 2010). Growth 
cones were found to turn toward the source of SR11237 (both concentrations combined) with 
an overall mean turning angle of 35.5 ± 6.1° (n=10; Figure 21A-B). A graphical 
representation of individual growth cone turning angles in response to SR11237 at each 
concentration is shown in Figure 21C. These data indicated that the new, commercially 
available RXR pan-agonist does indeed mimic the effects of atRA on growth cone behaviour.  
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SR11237 (Selective RXR pan agonist) 
                        A.t= 0                                                  B. t= 48 
        
C.  
 
 
Figure 21. Growth cones are attracted to a gradient of the SR11237.                                    
(A-B) Representative images depicting the turning response of a growth cone toward a local 
gradient of SR11237 (10-5M). The pipette tip is shown in the right hand corner (B). C. A graph 
showing the individual maximum turning angles toward the SR11237 at two different 
concentrations (10-5M and 10-6M; n=10). Growth cones were found to turn toward the source of 
SR11237 with a mean turning angle of 31.2 ± 7.8° (10-5M; n=5) or 39.8 ± 9.8° (10-6M; n=5). 
Times (t) are given in minutes. Scale bars = 15μm. 
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The mean turning angles in response to each retinoid are summarized in Figure 22. 
Statistical analysis using a Kruskal-Wallis One Way ANOVA on Ranks showed a significant 
effect of retinoid treatment (F (4, 50) = 9.478; p<0.001). Post-hoc analysis using a Tukey-
Kramer test indicated that the overall mean turning angle produced by atRA, EC23, and 
SR11237 was significantly greater than that produced by the vehicle alone (* p<0.001; 
Figure 22). CH55, a synthetic retinoid that has high affinity for RAR-α/β receptors, did not 
produce a significantly greater positive turning angle when compared to the vehicle, and was 
also significantly smaller than that produced by atRA (#p<0.05; Figure 22).  
Taken together, these data demonstrate that both the synthetic analog of atRA (EC23) 
and the RXR agonist (SR11237) mimicked the effects of atRA in inducing positive growth 
cone turning. Though the RAR agonist CH55 could induce growth cone turning of some 
individual growth cones, overall, the mean growth cone turning angle was not significantly 
different from the vehicle.   
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Figure 22. Summary of growth cone responses to retinoids. Summary graph comparing the 
mean turning angles of growth cones in response to the vehicle, atRA, EC23, CH55, or SR11237. 
Error bars represent the standard error of the mean (S.E.M.). Statistical analysis used a Kruskal-
Wallis One Way ANOVA on Ranks (F(4,50)= 9.478 (p<0.001) followed by a Tukey-Kramer post-
hoc test. The overall mean turning angle produced by atRA, EC23, and SR11237 was 
significantly larger when compared to that elicited by the vehicle (*p<0.001). CH55 did not 
produce a significantly larger response when compared to the vehicle, and the mean turning angle 
towards CH55 was significantly smaller than that of atRA (#p<0.05). N values for each treatment 
are provided in brackets.             
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The Role of Rho GTPase Rac in atRA-induced Growth Cone Turning 
It has been previously shown that calcium influx is required for atRA-induced growth 
cone turning (Farrar et. al., 2009). Rho GTPases are downstream effectors of calcium and are 
involved in some growth cone responses to other guidance cues (Kaufman et. al., 1998; 
Rajnicek et. al., 2006). We next investigated the possible role of the Rho GTPase, Rac, in 
atRA-mediated growth cone turning.  
To determine the potential role of Rac, the growth cone turning response to atRA was 
tested in the presence of the Rac inhibitor, NSC23766 (10
-4
M final bath concentration), and 
compared to growth cone responses to atRA in the absence of the Rac inhibitor. In the 
absence of the Rac inhibitor, the growth cones turn toward the source of atRA with a mean 
turning angle of 44.0 ± 4.7° (n=11; Figure 23 A-C). However, in the presence of the Rac 
inhibitor, the growth cones failed to turn toward the source of atRA (mean turning angle: -
8.8± 3.7
o
; n=10; Figure 23 D-F).  
In addition to preventing the chemoattractive response to atRA, the Rac inhibitor also 
appeared to induce a switch in the growth cone response. That is, the growth cones collapsed 
and retracted during the application of atRA. Growth cone collapse is indicative of an 
avoidance response to a chemorepulsive guidance cue. However, it is possible that the 
presence of the Rac inhibitor in the bath may have made the growth cones generally more 
susceptible to the pressure applied from the pipette and that the growth cone collapse 
observed was thus not a switch in responsiveness to atRA. In order to rule out this possibility, 
control experiments were performed whereby the vehicle alone was applied from a pipette to 
advancing growth cones in the presence of the Rac inhibitor. Though we would not expect 
the growth cone to exhibit any turning response to the vehicle, if the growth cone collapsing 
response was merely due to pressure artifact, we would expect to observe this response with 
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application of vehicle alone. However, the growth cones continued to actively advance in the 
presence of the vehicle, suggesting that the growth cone collapse in response to atRA was not 
due to pressure artifact. As expected, the growth cones did not turn toward the vehicle (mean 
turning angle of 1.2 ± 3.1
o
; n=10; Figure 23 G-I). Graphs showing the maximum turning 
angles to atRA in the absence and presence of the Rac inhibitor in the bath, and to the vehicle 
in the presence of the Rac inhibitor, are shown in Figure 23 C, F, and I, respectively.  
A summary of the mean growth cone turning angle are shown in Figure 24. Statistical 
analysis using a Kruskal-Wallis One Way ANOVA on Ranks showed a significant effect       
(F (2, 28)= 51.873; p<0.001) and a Tukey-Kramer post-hoc test indicated that the overall mean 
turning angle toward atRA in the absence of the Rac inhibitor was significantly different 
from the mean turning angle toward atRA (p<0.001) and the vehicle (p<0.001), in the 
presence of the Rac inhibitor (Figure 24). These data indicate that Rac may indeed play an 
important role in mediating atRA-induced growth cone turning.    
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atRA                                                                                                                                                                
A. t=0                                     B. t=53                                      C.                    
                  
atRA applied in presence of Rac inhibitor                                                                                                                                                                  
D. t=0                                    E. t=30                                    F.                   
                        
Vehicle applied in presence of Rac inhibitor                                                                                                                                                                 
G. t=0                                     H. t=40                                   I.                                  
    
 
Figure 23. A switch in the growth cone turning response to atRA in the presence of the Rac 
inhibitor. Representative images depicting the turning response of a growth cone to atRA in the 
absence (A-B) or presence (D-E) of the Rac inhibitor in the bath. Note the growth cone collapse 
shown in E. Vehicle alone was also applied in the presence of the Rac inhibitor (G-H). The 
pipette tip is shown in the right hand corner (B, E, H). Graphs showing the maximum turning 
angles of each individual growth cone in each condition are shown in C (n=11), F (n=10), and I 
(n=10). Individual growth cones are numbered on the y axis of the graphs. The findings shown in 
C were obtained from Figure 18 and are shown again for comparison. Times (t) are given in 
minutes. Scale bars = 15μm. 
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Pipette:                      atRA                                  atRA                                  Vehicle 
Bath:                         -------                               NSC23766                          NSC23766 
 
Figure 24. Growth cones fail to turn towards atRA in the presence of Rac inhibitor. 
Summary graph comparing the mean turning angles of growth cones in response to atRA in the 
absence or presence of the Rac inhibitor. Statistical analysis used a Kruskal-Wallis One Way 
ANOVA on Ranks (F(2, 28)= 51.873 (p<0.001) followed by with a Tukey-Kramer post-hoc test. 
Error bars represent the standard error of the mean (S.E.M.).The overall mean turning angle in 
response to atRA in the absence of the Rac inhibitor was significantly different from the mean 
turning angle in response to atRA (*p<0.001) or the vehicle (*p<0.001), in the presence of the 
Rac inhibitor in the bath. N values for each treatment are provided in brackets.       
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In order to determine whether the Rac inhibitor did indeed induce a stalling and 
retraction (collapse) of growth cones in response to atRA, we also determined the extent of 
growth cone advancement over the duration of each experiment. Graphs show the length of 
advancement of individual growth cones in response to atRA (in the absence (Figure 25A) or 
presence (Figure 25 B) of the Rac inhibitor) as well as to the application of the vehicle in the 
presence of the Rac inhibitor (Figure 25 C). The mean advancement of the growth cones in 
each condition are summarized in Figure 25 D. Statistical analysis using a Kruskal-Wallis 
One Way ANOVA on Ranks indicated a statistical difference (F(2, 28)= 11.849 (p<0.001)) and 
a Tukey-Kramer post-hoc test revealed that in the presence of the Rac inhibitor, growth cone 
advancement was significantly reduced in response to atRA (-6.7 ± 6.0 μm), compared to in 
the absence of the inhibitor (25.0 ± 4.1µm; p<0.001; Figure 25 D). Furthermore, in the 
presence of the Rac inhibitor, growth cone advancement in response to atRA was 
significantly less than to application of the vehicle alone (p=0.001; Figure 25 D).  
In summary, these findings strongly suggest that the Rac inhibitor not only blocks 
growth cone turning towards atRA, but also induces a switch in response to atRA, which 
involved growth cone collapse and retraction (inhibition of growth cone advancement).  
 
 
 
 
 
 
 
 
 
72 
 
A. atRA                                       B. atRA in Rac inhibitor         C. Vehicle in Rac inhibitor                                                                                                                                                                 
       
 
D.  
 
Pipette:                       atRA                               atRA                              Vehicle 
Bath:                          -------                             NSC23766                    NSC23766 
 
Figure 25. Rac inhibitor blocks growth cone advancement in response to atRA application. 
Graphs showing the length of growth cone advancement in response to atRA in the absence 
(n=11; A) or presence (n=10; B) of the Rac inhibitor or to the vehicle applied in the presence of 
the Rac inhibitor (n=10; C) over a time course of 50 to 60 minutes. Individual growth cones are 
numbered on the x axis of the graphs. D. Summary graph comparing the mean length of 
advancement of neurites in each condition. Error bars represent the standard error of the mean 
(S.E.M.). Statistical analysis was performed using a Kruskal-Wallis One Way ANOVA on Ranks 
(F(2, 28) = 11.849; *p<0.001) followed by a Tukey-Kramer post-hoc test. In the presence of the 
Rac inhibitor, growth cone advancement was significantly reduced in response to atRA 
(#p<0.001 compared to in the absence of Rac inhibitor; *p=0.001 compared to vehicle).  N 
values for each treatment are provided in brackets.     
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The Role of Rac in EC23-induced Growth Cone Turning 
We have previously determined that EC23 mimics atRA-induced growth cone 
turning, and the data suggests that Rac may be involved in growth cone turning towards 
atRA. Hence, my next aim was to determine whether the Rac inhibitor would also abolish 
EC23-induced growth cone turning.  
EC23 normally induces growth cone turning with a mean angle of 33.7 ± 6.5µm 
(Figure 26 A-B; n=10). In the presence of the Rac inhibitor, the growth cones continued to 
turn towards the focally applied EC23, albeit it with a smaller mean turning angle of 17.9 ± 
6.4
o 
(Figure 26 D-E; n=10). Furthermore, growth cones continued to advance following 
application of EC23, and did not exhibit growth cone collapse as they had previously in 
response to atRA. Graphs showing the maximum turning angles of each individual growth 
cone in response to EC23 in the absence and presence of the Rac inhibitor are shown in 
Figure 26 C and F respectively.  
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EC23 applied in the absence of Rac inhibitor     
A. t= 0                                   B.  t= 53                                   C. 
   
 
 
EC23 applied in the presence of Rac inhibitor 
D. t= 0                                       E. t= 40                                         F. 
  
 
Figure 26. Rac inhibitor does not block EC23 mediated growth cone turning.  Representative 
images depicting the turning response of a growth cone to a local gradient of the EC23 in the 
absence (A-B) or presence (D-E) of the Rac inhibitor. The pipette tip is shown on the right side 
of image (B, E). Graphs showing the maximum turning angles of individual growth cones toward 
EC23 in the absence (C; n=10) or presence (F; n=10) of the Rac inhibitor. Individual growth 
cones are numbered on the y axis of the graphs. The findings shown in C were obtained from 
Figure 19 and are shown again for comparison. Times (t) are given in minutes. Scale bars = 
15μm. 
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In order to compare the effects of the Rac inhibitor on the chemoattractive responses 
of both atRA and EC23, the growth cone turning angles are summarized in Figure 27. 
Statistical analysis was performed using a Two Way ANOVA and revealed a significant 
interaction effect between the bath treatment (Rac inhibitor) and the retinoid applied to the 
growth cone (F (1, 37) = 11.69; p =0.002).  As shown previously, a Holm–Bonferroni 
Sequential Correction post-hoc test showed that there was a significant reduction in growth 
cone turning towards atRA in the presence of the Rac inhibitor as compared to in its absence 
(p<0.0125, Holm-Bonferroni sequential corrected p value; Figure 27). Furthermore, in the 
presence of the Rac inhibitor, the growth cone turning angle was significantly smaller in 
response to atRA than in response to EC23 (p<0.017, Holm-Bonferroni sequential corrected 
p value; Figure 27). Although the mean turning angle in response to EC23 was smaller in the 
presence of the Rac inhibitor, this reduction did not reach statistical significance (p>0.025, 
Holm-Bonferroni sequential corrected p value; Figure 27).  
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Pipette:                   atRA                       atRA                         EC23                        EC23  
Bath:                      -------                   NSC23766                   -------                     NSC23766 
 
Figure 27. Rac inhibitor blocks growth cone turning in response to atRA but not in 
response to EC23. Summary graph comparing the mean turning angles of growth cones in 
response to atRA or EC23, in the presence or absence of the Rac inhibitor. Error bars represent 
the standard error of the mean (S.E.M.).Statistical analysis used a Two Way ANOVA and 
revealed a significant interaction effect between the bath treatment (Rac inhibitor) and the 
retinoid applied (F(1,37)  = 11.69; p =0.002). A Holm–Bonferroni Sequential Correction post-hoc 
test indicates a significant reduction in the mean growth cone turning angle in response to atRA 
in the presence of the Rac inhibitor as compared to in its absence (*p<0.0125). There was also a 
significant reduction in the mean growth cone turning angle in response to atRA compared to 
EC23 in the presence of the Rac inhibitor (#p<0.017). N values for each treatment are provided 
in brackets.  
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In order to determine whether the Rac inhibitor induced any stalling and retraction of 
growth cones in response to EC23, we also determined the extent of growth cone 
advancement over the duration of each experiment. Graphs showing the length of 
advancement of individual growth cones in response to EC23 in the absence and presence of 
the Rac inhibitor are shown in Figure 28 A and B, respectively. Furthermore, a summary 
graph comparing the growth cone advancement in response to EC23 compared with atRA are 
also summarized in Figure 28 C. A Two Way ANOVA revealed a significant interaction 
effect of bath treatment (Rac inhibitor) and the retinoid applied (F (1, 37) = 12.06; p =0.001). A 
Holm–Bonferroni Sequential Correction post-hoc test confirmed a significant reduction in 
growth cone advancement in response to atRA in the presence of the Rac inhibitor, compared 
to in its absence (*p<0.0125, Holm-Bonferroni sequential corrected p value; Figure 28); 
whereas there was no such reduction for EC23 (p=0.792 (>0.025, Holm-Bonferroni 
sequential corrected p value); Figure 28). However, there was a significant reduction in 
growth cone advancement in response to atRA compared to advancement in EC23 in the 
presence of the Rac inhibitor (#p<0.017, Holm-Bonferroni sequential corrected p value; 
Figure 28).  
In summary, these data suggest that the Rac inhibitor induces a significant inhibition 
of growth cone turning responses to atRA, but not to the synthetic retinoid EC23. Moreover, 
the data have shown that the Rac inhibitor induces a switch in the growth cone response to 
atRA, from chemoattraction to growth cone collapse and retraction. This inhibition of growth 
cone turning, or switching of growth cone response to chemorepulsion did not occur in 
response to the synthetic retinoid EC23 in the presence of the Rac inhibitor.   
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                              A. EC23                                          B. EC23 in Rac inhibitor 
     
 
C.  
 
Pipette:                               atRA                     atRA                     EC23                    EC23      
Bath:                                  -------                 NSC23766                -------                NSC23766 
 
Figure 28. Rac inhibitor blocks growth cone advancement in response to atRA but not in 
response to EC23. Graphs showing the length of growth cone advancement in response to EC23 
in the absence (n=10; A) or presence (n=10; B) of the Rac inhibitor. Individual growth cones are 
numbered on the x axis of the graphs. C. Summary graph comparing the mean length of 
advancement of neurites in response to atRA or EC23, in the presence or absence of the Rac 
inhibitor. Error bars represent the standard error of the mean (S.E.M.). A Two Way ANOVA 
revealed a significant interaction effect between the bath treatment (Rac inhibitor) and the 
retinoid applied (F (1, 37) = 12.06; p =0.001). A Holm–Bonferroni Sequential Correction post-hoc 
test indicates the Rac inhibitor significantly reduced growth cone advancement in response to 
atRA (*p<0.0125). There was also a significant reduction in growth cone advancement in 
response to atRA compared with EC23 in the presence of the Rac inhibitor (#p<0.017). N values 
for each treatment are provided in brackets. 
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The Rac Inhibitor Does Not Inhibit atRA-Induced Growth Cone Turning of Isolated 
Growth Cones 
It has been shown that atRA-induced growth cone turning is transcriptionally 
independent and relies on the local synthesis of proteins in growth cones (Farrar et al., 2009). 
That is, previous studies have shown that growth cones isolated from the cell body continue 
to respond to atRA (Farrar et. al., 2009). An advantage of using cultured Lymnaea neurons is 
that neurites can survive transection from the cell body and can continue to grow for many 
hours. After identifying that the Rac inhibitor induced a switch in the response of growth 
cones in response to atRA, my next aim was to determine whether the inhibition of Rac 
would also attenuate growth cone turning and advancement of transected growth cones. This 
could shed light on whether the involvement of Rac in growth cone turning relies on 
communication from the cell body. 
The response of transected growth cones to atRA was first tested, to ensure 
repeatability of previous findings (Farrar et. al., 2009). A local gradient of atRA (10
-5 
M) was 
applied to advancing transected growth cones (in the absence of the Rac inhibitor). Growth 
cones were found to turn and advance toward the source of atRA (pipette) with a mean 
turning angle of 39.1 ± 5.4 ° (n=13; Figure 29 A-B). Interestingly, in the presence of the Rac 
inhibitor, the transected growth cones continued to turn and advance towards the focally 
applied atRA with a mean turning angle of 25.7 ± 4.5
o 
(n=31; Figure 29 D-E). Graphs 
showing maximum turning angles of each individual transected growth cone in response to 
atRA, in the absence or presence of the Rac inhibitor, are shown in Figure 29 C and F 
respectively.  
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Transected growth cone response to atRA in the absence of Rac inhibitor                                                                      
A. t=0                                                   B. t=30                              C.                            
           
 
 
 
Transected growth cone response to atRA in the presence of Rac inhibitor                                                                     
D. t=0                                                   E. t=35                                F. 
      
 
 
 
Figure 29. Rac inhibitor does not block transected growth cone turning towards atRA. 
Representative images depicting the turning response of a transected growth cone to a local 
gradient of atRA, in the absence (A-B) or presence of the Rac inhibitor in the bath (D-E). The 
pipette tip is shown on the right side of the images (B, E). Graphs showing the maximum turning 
angles of individual growth cones to atRA, in the absence (C; n=13) or presence (F; n=12) of the 
Rac inhibitor in the bath. Individual growth cones are numbered on the y axis of the graphs. 
Times (t) are given in minutes. Scale bars = 15μm 
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The mean turning angles of intact or transected growth cones towards atRA, in the 
absence or presence of the Rac inhibitor, are summarized in Figure 30. A Two Way ANOVA 
revealed a significant interaction effect between the bath treatment (Rac inhibitor) and the 
condition of the growth cone (F (1, 42) = 17.032; p <0.001).  Holm–Bonferroni Sequential 
Correction post-hoc test confirmed a significant reduction in intact growth cone turning 
towards atRA in the presence of the Rac inhibitor as compared to in its absence (p<0.0125, 
Holm-Bonferroni sequential corrected p value; Figure 30). The growth cone turning of intact 
neurites to atRA in the Rac inhibitor was significantly reduced compared to that of transected 
growth cones in the same condition (p<0.0125, Holm-Bonferroni sequential corrected p 
value; Figure 30).  
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Pipette                    atRA                        atRA                         atRA                          atRA 
Bath:                     -------                     NSC23766                  -------                      NSC23766 
Neurite Condition: Intact                      Intact                    Transected                 Transected 
 
Figure 30. Rac inhibitor does not block transected growth cone turning towards atRA. 
Summary graph comparing the mean turning angles of intact and transected growth cones in 
response to atRA, in presence or absence of the Rac inhibitor. Error bars represent the standard 
error of the mean (S.E.M.). A Two Way ANOVA revealed a significant interaction effect 
between the bath treatment with the Rac inhibitor and the transection of the growth cone (F(1,42) = 
17.032; p <0.001).  A Holm–Bonferroni Sequential Correction post-hoc test indicates a 
significant reduction in intact growth cone turning towards atRA in the presence of the Rac 
inhibitor as compared to in its absence (*p<0.0125). There was also a significant difference 
between intact and transected growth cone turning in response to atRA (*p<0.0125). N values for 
each treatment are provided in brackets.  
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In order to determine whether the Rac inhibitor induced a stalling and retraction of 
transected growth cones in response to atRA, we also determined the extent of growth cone 
advancement over the duration of each experiment. Graphs showing the length of 
advancement of individual growth cones to atRA in the absence and presence of the Rac 
inhibitor are shown in Figure 31 A and B, respectively. Furthermore, a summary graph 
comparing the advancement of intact, compared with transected growth cones, is shown in 
Figure 31 C. A Two Way ANOVA revealed a significant interaction effect of bath treatment 
(Rac inhibitor) and the condition of the growth cone (intact or transected) (F (1, 42) = 14.478; 
p <0.001). A Holm–Bonferroni Sequential Correction post-hoc test revealed a significant 
reduction in intact growth cone advancement in response atRA in the presence of the Rac 
inhibitor as compared to in its absence (p<0.0125, Holm-Bonferroni sequential corrected p 
value; Figure 31). There was also a significant reduction in the advancement of intact growth 
cones towards atRA compared to transected growth cones, in the presence of the Rac 
inhibitor (p<0.017, Holm-Bonferroni sequential corrected p value; Figure 31).  
In summary, studies have shown that the Rac inhibitor induces a switch in growth 
cone response (of intact growth cones) to atRA from chemoattraction to chemorepulsion. 
That is, growth cones collapsed and retracted in response to atRA when the Rac inhibitor was 
present. Interestingly, however, the Rac inhibitor did not induce the same significant effects 
on the response of growth cones to the synthetic retinoid EC23. Moreover, the Rac inhibitor 
did not induce the same effects on growth cones transected from the cell body. These data 
suggest that the involvement of Rac in growth cone turning may differ depending on whether 
the turning is induced by endogenous or synthetic retinoids, and also whether the growth 
cones have maintained communication with the cell body.  
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               Transected growth cone response to atRA: 
A. Absence of Rac inhibitor                      B. Presence of Rac inhibitor                                                         
     
 
C. 
 
Pipette:                   atRA                     atRA                      atRA                       atRA 
Bath:                      -------               NSC23766                  -------                 NSC23766 
Neurite condition: Intact                   Intact                   Transected              Transected 
 
Figure 31. Rac inhibitor blocks growth cone advancement of intact, but not transected, 
neurites in response to atRA. Graphs showing the length of transected growth cone 
advancement in response to atRA in the absence (n=13; A) or presence (n=12; B) of the Rac 
inhibitor. Individual growth cones are numbered on the x axis of the graphs. C. Summary graph 
comparing the mean length of advancement of intact or transected growth cones in response to 
atRA, in the presence or absence of the Rac inhibitor. Error bars represent the standard error of 
the mean (S.E.M.). A Two Way ANOVA revealed a significant interaction effect between the 
bath treatment with the Rac inhibitor and the condition of the growth cone (intact or transected) 
(F(1,42) = 11.478; p <0.001). A Holm–Bonferroni Sequential Correction post-hoc test indicates that 
the Rac inhibitor significantly reduced intact growth cone advancement to atRA (*p<0.0125). 
There was also a significant reduction in intact growth cone advancement towards atRA 
compared with transected growth cones (#p<0.017) in the presence of the Rac inhibitor. N values 
for each treatment are provided in brackets.  
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3.04 Discussion  
The potential role of LymRAR and LymRXR in retinoic acid-induced growth cone 
turning 
Retinoic acid is a molecule that has been implicated in several developmental and 
regenerative processes, including acting as a chemoattractant to guide regenerating axons in 
vertebrates (Dmetrichuk et. al., 2005) and invertebrates such as Lymnaea (Dmetrichuk et. al., 
2006; 2008). The main effects of retinoic acid in regeneration are thought to occur via 
signalling through receptors, which include RARs and RXRs. Recently, in the mollusc 
Lymnaea, an RXR and a putative RAR have been cloned (Carter et. al., 2010, 2015). 
However, there has been limited study of these receptors to date, and the mechanisms 
underlying the tropic effects of retinoic acid in Lymnaea remain largely unknown. Since 
identifying the localization of LymRAR and LymRXR in the neurites and specifically in the 
growth cones of cultured neurons (Carter et. al., 2010; 2015), a role for both retinoid 
receptors in retinoic acid-mediated growth cone guidance has been proposed. Hence, we 
sought to further investigate the response of cultured Lymnaea PeA neurites to various 
synthetic retinoids, in order to gain more insight into the potential role of LymRAR and 
LymRXR in retinoic acid-mediated growth cone turning.  
Carter et. al. (2010) first tested a RXR agonist, PA024, and found that it was able to 
mimic retinoic acid and induce growth cone turning in both intact and isolated neurites of 
Lymnaea. However, this agonist is no longer available for use. Furthermore, no RAR 
agonists have previously been shown to mimic the action of atRA. Therefore, we chose to 
test the effects of the RAR agonists: EC23 and CH55, as well as a new commercially 
available RXR pan agonist, SR11237, on the growth cone turning behaviour of Lymnaea 
neurites.  
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We determined that both RAR and RXR agonists can indeed mimic the 
chemoattractive effects of atRA in cultured regenerating Lymnaea neurons. We showed that 
Lymnaea PeA motorneurons are attracted to EC23, an analog of atRA, and SR11237, an 
RXR pan-agonist. Indeed, EC23 has been shown in previous vertebrate studies to display 
similar biological activity to atRA (Christie et. al., 2008; Maltman et. al., 2009), as has 
SR11237 to 9-cis retinoic acid (Lehmann et. al., 1992; Zhou et. al., 2010). However, the 
synthetic retinoid, CH55 produced ambiguous results in the growth cone turning assays. 
Some growth cones turned towards CH55, while others did not. Although the mean turning 
angle towards CH55 was positive, it was not significantly different from the growth cone 
response to the vehicle alone. This ambiguity contradicts previous findings in vertebrates that 
found CH55 exhibited potent retinoid-like activity in both stimulatory and inhibitory 
biological processes (Sato, 1988). For example, CH55 induced differentiation of embryonal 
carcinoma F9 cells and inhibited the growth of melanoma S91 cells, in a similar manner to 
atRA (Jetten et. al., 1987).  
Differences in the binding affinity of EC23 and CH55 to LymRAR may account for 
the difference in the responses observed. Although both these RAR agonists show higher 
binding affinities to RAR compared to atRA in vertebrates (Gambone et. al., 2002; 
Hashimoto et. al., 1990), the synthetic retinoids may not bind as efficiently with LymRAR 
and CH55 may bind less efficiently than EC23. Indeed, previous studies in Lymnaea have 
also found EC23 to be more potent than CH55 in disrupting embryonic development (de 
Hoog, 2015). These findings suggest that CH55 may have poor binding affinity to retinoid 
receptors in Lymnaea, which may account for the lack of an overall significant positive effect 
on growth cone turning (despite some individual positive growth cone responses).  
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It is also possible that the different synthetic retinoids might activate different 
intracellular signalling pathways downstream of the retinoid receptors, compared to atRA, 
and this might also account for differences in the turning responses observed. Although 
synthetic retinoids can elicit the same biological response as retinoic acid, they might do so 
through different/diverging cellular mechanism(s). For example, this has been suggested 
previously for CH55, which was found to activate a different intracellular signalling pathway 
than atRA in rabbit tracheal epithelial cells (Jetten et. al., 1987). Moreover, previous findings 
have suggested that retinoic acid may also induce signal transduction pathways independent 
of binding to RAR and RXR. For example, retinoic acid can activate cyclic adenosine 
monophosphate response element-binding protein (CREB) independent of RAR and RXR in 
human tracheobronchial epithelial cells (Aggarwal et. al., 2006) and direct interactions 
between retinoic acid and  protein kinase A (PKA) have been documented (Wong et. al., 
2006; Saito et. al., 2010). Therefore, in addition to binding to RAR and/or RXR, atRA may 
also be exerting additional or parallel actions via receptor-independent pathways. Taken 
together, these findings still support a potential role for LymRAR and LymRXR in retinoic 
acid-mediated growth cone turning, though further studies will be needed to examine the 
pathways involved in more detail.  
 
The role of Rac in atRA-induced growth cone turning 
Although previous studies have provided some evidence for the role of neuritically 
localized retinoid receptors in the chemoattractive effects of retinoic acid, far less is known 
of potential downstream effectors in this response. To date, retinoic acid-mediated growth 
cone turning has been shown to require both local protein synthesis and calcium influx 
(Farrar et. al., 2009). However, the signalling cascades which might link calcium influx to 
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the regulation of cytoskeletal dynamics involved in growth cone turning are not currently 
known. Rho GTPases are known downstream effectors of calcium and are involved in 
growth cone responses to other guidance cues (Kaufman et. al., 1998; Rajnicek et. al., 2006). 
However, whether Rho GTPases play a role in retinoic acid-induced chemoattraction had not 
previously been studied. My aim was to determine the possible role of the Rho GTPase Rac 
in retinoic acid-mediated growth cone turning in regenerating Lymnaea neurons. 
Previous studies have shown that growth cones of Lymnaea PeA neurites turn and 
extend towards focally applied atRA (Farrar et. al., 2009). However, in the presence of the 
Rac inhibitor, we showed an inhibition of growth cone turning to atRA. This demonstration, 
that Rac prevented chemotropic growth cone attraction, is in agreement with several studies 
that have also suggested a positive role for Rac in the directional migration of growth cones. 
For example, genetic disruption of Rac activity was found to result in growth cone 
pathfinding defects of motor axons in Drosophila embryos (Kaufman et. al., 1998) and of 
spinal neurons in Xenopus embryos (Rajnicek et. al., 2006). Rac has also been found to 
mediate growth cone attraction to netrin in rat embryonic spinal cord explants (Li et. al., 
2002).  
In addition to the inhibition of growth cone turning, a switching in the response to 
atRA was observed in the presence of the Rac inhbitor. The growth cones were found to 
collapse and retract in the presence of atRA, which is indicative of chemorepulsion. This 
chemorepulsive response was specific to application of atRA, as it did not occur on 
application of the vehicle, and thus was not a pressure artifact. Similarly, previous studies 
have also shown a switch in the response of Xenopus growth cones to the chemoattractant 
BDNF, following the inhibition of all three Rho GTPases, Rac, CdC42, and Rho (Yuan et. 
al., 2003). Other studies have also shown a similar switch in Xenopus growth cones’ 
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response after pharmacological manipulation of cyclic adenosine monophosphate (cAMP) or 
cAMP-dependent kinases, such as PKA (Song et al., 1998). That is, in the presence of a 
competitive analogue of cAMP or a specific inhibitor of PKA, a gradient of BDNF (or 
acetylcholine), which normally triggered an attractive turning response, induced a repulsive 
turning response of Xenopus spinal growth cones (Song et al., 1997).  As there is evidence 
that Rac activation can be controlled by cAMP/PKA mediated-signalling (in the directed 
migration of carcinoma cells; O’Connor and Mercurio, 2001), it is possible that the switch in 
response to atRA observed here may result from an interaction between Rac and cAMP 
levels within the growth cone.   
Furthermore, recent studies postulated that attractive growth cone turning entails the 
accumulation of functional membrane receptors and cytoskeletal components on the side of 
the growth cone closest to the chemoattractant (Bouzigues et. al., 2007). Although, in 
Lymnaea, retinoid receptors were detected in the membrane and cytoplasmic fractions of 
neurons (Carter et. al., 2010; 2015), whether retinoid receptors are redistributed to the side of 
the growth cone closest to retinoic acid, and where (cytoplasm or membrane) retinoic acid 
binds retinoid receptors to initiate growth cone turning, need to be determined. If retinoid 
receptors are indeed asymmetrically redistributed during attractive growth cone turning, Rho 
GTPases may be involved in facilitating their transportation, through cytoskeletal-dependant 
vesicle transport. Several proteins that regulate the assembly of the actin cytoskeleton, 
including actin-binding proteins, have been shown to be downstream effectors of Rho 
GTPases (Hall, 2005). Nonetheless, in summary, these findings suggest that intracellular 
signal transduction pathways involving Rac, may mediate the response of growth cones to 
guidance cues such as retinoic acid.  
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The role of Rac in EC23-induced growth cone turning 
My data suggests that Rac may be a downstream effector of atRA to induce growth 
cone turning. Since EC23 was shown to mimic atRA-induced growth cone turning, we also 
sought to determine whether the Rac inhibitor may also be involved in EC23-mediated 
growth cone turning. However, in the presence of the Rac inhibitor, the growth cones 
continued to advance in response to EC23 and did not exhibit growth cone collapse and 
retraction as they had in response to atRA. Although there was substantial reduction in the 
mean turning angle towards EC23 in the presence of the Rac inhibitor (as compared to in its 
absence), the growth cones continued to turn towards EC23.  
It is possible that the endogenous ligand, atRA, may be acting through intracellular 
signalling pathways different from that of EC23, which may explain the differences in the 
growth cone responses observed here. As mentioned previously, the synthetic retinoid CH55 
was shown to activate different intracellular pathways than atRA (Jetten et. al., 1987). This 
may also be true for EC23, which may activate intracellular pathways that are independent of 
Rac. Moreover, the effects mediated by atRA may not be exclusively through the RAR or 
RXR receptor, and these non-receptor mediated effects may require Rac signalling. For 
example, there is evidence for the direct modulation of protein kinase C (PKC) signalling by 
retinoic acid, and PKC has a retinoic acid-binding site (Radominska-Pandya et al., 2000; 
Ochoa et al., 2003). Retinoic acid can also activate cAMP response element-binding protein 
(CREB) independent of RAR and RXR in human tracheobronchial epithelial cells (Aggarwal 
et al. 2006). Interestingly, both PKC and CREB have previously been found to interact with 
Rho GTPases (Slater et. al., 2001; Sordella et. al., 2002; Kanazawa et. al., 2014).  
Alternatively, EC23 may be having more potent or prolonged effects on downstream 
activators that the Rac inhibitor could not overcome. For example, EC23 has been found to 
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be more potent than atRA in inducing neural differentiation in human pluripotent embryonic 
stem cells (Christie et. al., 2008). EC23 induces higher CRABP-I expression (a protein that 
sequesters retinoic acid), compared to atRA (Maltman et. al., 2009). Although there is 
currently no evidence that EC23 could also be sequestered by CRABP-I, the differential 
effects of EC23 on CRABP-I expression, compared to atRA, may explain enhanced activity 
associated with EC23. EC23 may also exhibit an increased resistance to cellular metabolism 
compared to atRA. For example, there appears to be no evidence that EC23 is degraded by 
CYP26A1, an enzyme that is responsible for degrading endogenous retinoids (Reijntjes et. 
al., 2005), and EC23 elicits a weaker induction of CYP26A1 expression, compared to atRA 
(Haffez et. al., 2007). Therefore, these differences in binding affinities or metabolism might 
result in prolonged effects of EC23, compared to atRA, and may help explain the persistence 
of the growth cone turning in response to EC23, even after Rac inhibition.  
 
The role of Rac in atRA-induced turning of isolated growth cones 
Previous studies have shown that Lymnaea growth cones, isolated from the cell body, 
continue to exhibit turning in response to atRA (Farrar et. al., 2009). These growth cone 
responses to atRA were shown to rely on calcium influx and the local synthesis of proteins 
(Farrar et. al., 2009). After identifying that the Rac inhibitor induced a switch in the response 
of growth cones towards atRA, we also determined whether the inhibition of Rac would 
induce similar effects on transected growth cones. Unlike the intact growth cones, the 
transected growth cones continued to turn and advance towards the focally applied atRA in 
the presence of the Rac inhibitor.  However, a substantial (albeit non-significant) reduction in 
the mean turning angle was observed in the Rac inhibitor, which suggests that Rac might still 
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play some role in the transected growth cones, but not to the same extent as it does in intact 
growth cones.  
It is possible that transection of the growth cones might have initiated a compensatory 
mechanism that may be either independent of Rac, or that relies on alternative guanine 
nucleotide exchange factors (GEFs) to activate Rac. Rac is activated when GEFs catalyze the 
exchange of GDP for GTP (Gao et. al., 2004). The Rac inhibitor used in my experiments, 
NSC23766, supposedly binds to Rac and targets the interaction between Rac and a subset of 
its GEFs: Tiam1 and Trio. However, there are several other GEFs that have been shown to 
activate Rac such as phosphatidylinositol (3,4,5)-trisphosphate-dependent Rac exchanger 2 
(P-Rex2) (Donald et. al., 2004). It could be possible that alternative GEFs may have allowed 
the activity of Rac to persist. It could also be possible that transection of the growth cones 
could have impeded the effects of the Rac inhibitor. That is, inhibiting Rac activity in the cell 
might be facilitated by cross talk with upstream effectors or genomic processes. Previous 
studies have confirmed communication between the growth cones and the cell body through 
rapid generation of calcium waves (Guan et al., 2007) and active transport of vesicles to and 
from the cell body (Denburg et al., 2005). These vesicles could be transporting regulatory 
proteins and signalling ligands that may have been facilitating inhibition of Rac by the 
NSC23766.  
In summary, these studies demonstrated the ability of a number of synthetic retinoid 
agonists to mimic atRA to induce growth cone turning. We also showed for the first time that 
the intracellular signalling pathway involved in growth cone turning is likely to involve the 
Rho GTPase, Rac. However, the involvement of Rac in growth cone turning may differ 
depending on whether the turning is induced by endogenous or synthetic retinoids, and also 
whether the growth cones have communication with the cell body.  
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Understanding the processes underlying neuronal regeneration is a major goal of 
research. Many signaling molecules that were once thought to only be important during 
neural development are now known to be just as important postnatally, including during 
neural regeneration. Due to the preservation of these signalling molecules in development 
and regeneration, many believe that neural regeneration may involve re-activation of the 
developmental signaling pathways. Therefore, research on neuronal regeneration may not 
only be used to understand the signalling pathways involved in enabling regeneration, but 
also possibly the signalling pathways involved in development.  
Retinoic acid is one of the signalling molecules that has been found to have a 
conserved role in neural development and regeneration. Retinoic acid signalling has been 
found to be involved in neuronal patterning, neural differentiation and axon outgrowth in the 
developing nervous system (Maden, 2007). Retinoic acid synthesis and signalling has also 
been shown to be up-regulated following injury in several species (Viviano et al. 1995; 
Zhelyaznik et. al., 2003). Following nerve damage, this molecule has the capacity to induce 
neural regeneration (Dmetrichuk et. al., 2005; Dmetrichuk et. al., 2006) as well as guide 
axonal processes (Dmetrichuk et. al., 2006; Dmetrichuk et. al., 2008). Moreover, the 
downregulation of retinoic acid signalling has been suggested to be at least partly involved in 
the loss of capacity to regenerate CNS neurons in some adult vertebrates. For example, 
supplementation with retinoic acid was not sufficient to induce neurite outgrowth in the adult 
mouse spinal cord, yet, neurite outgrowth was accomplished following the introduction of the 
retinoic acid receptor gene, RARβ2 (Corcoran et. al., 2002). Although retinoic acid and its 
various signaling components have been identified in adult species, and its role in adult 
regeneration has been implicated, the exact processes involved have not been fully 
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determined. Therefore, the fundamental pathway(s) through which retinoic acid elicits its 
effects during regeneration still require further characterization.  
Adult invertebrates that retain the ability to regenerate their CNS have been useful 
model systems to study regeneration. Lymnaea stagnalis, in particular, is well-established as 
a model system for regeneration. Unlike the adult mammalian CNS, the CNS of adult 
Lymnaea stagnalis is capable of extensive regeneration. Moreover, single identified neurons 
that have a well characterized morphology and function in the CNS have been successfully 
cultured from this model system. This model system can, therefore, be used to investigate the 
signalling pathways through which retinoic acid elicits its effects during neural regeneration.  
The CNS of adult Lymnaea stagnalis has been used in our lab to investigate the effect 
of retinoic acid on neurite outgrowth during regeneration. J. Simmons had determined that 
Lymnaea CNS floating on the surface of DM could exhibit neurite outgrowth (unpublished 
findings). When testing the effects of retinoid isomers on the neurite outgrowth from the 
floating CNS, my results were not consistent across concentrations. Despite this, the data in 
this thesis still suggest that 9-cis RA, unlike atRA, might be able to enhance neurite 
outgrowth from the floating CNS. There are several advantages to using this intact CNS 
preparation in studying the effects of retinoic acid on neurite outgrowth. One advantage is 
that studying the intact CNS allows us to study multiple cell types and axons within nerve 
bundles simultaneously, rather than just individual sensory or motor neurons (as with cell 
culture). Another advantage of using this preparation is the ability to observe large-scale 
changes (unlike with cultured neurons) which would more closely mimic an in vivo response. 
Promising findings from our lab (unpublished observations) have also demonstrated that 
outgrowth from the floating CNS could be harvested on coverslips for future immunostaining 
studies. Hence, there are several advantages to continue using the floating CNS preparation 
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to investigate the effects of retinoic acid on neurite outgrowth from the Lymnaea CNS. The 
experimental procedures for this novel preparation can be refined in future experiments to 
obtain more consistent results and verify whether there is indeed a trophic effect of 9-cis RA. 
In future experiments, it might be best to change the concentration of retinoic acid, or to add 
retinoic acid daily throughout the duration of the experiment to avoid degradation. 
Alternatively, various synthetic retinoids that mimic endogenous retinoids but are degraded 
less quickly could be used (Haffez et. al., 2017). 
The floating CNS model may also be useful for looking at the directional behaviour 
of neurite outgrowth emanating from cut nerves towards floating targets, such as neighboring 
nerve fragments and/or ganglia. In previous research, it was suggested that growth cone 
migration and axon elongation relies on adhesive contacts with solid substrates to occur 
(Gomez and Letourneau, 2014). However, we clearly showed here, for the first time, that 
growth cones can still sense atRA and respond in the absence of substrate adhesion. The 
tropic effects of retinoic acid were also only previously shown on Lymnaea motorneurons 
(Pedal A and Visceral F) in culture. However, the data in this thesis suggested that other cell 
types (though not identifiable) might also be responsive to atRA. Nevertheless, the floating 
CNS of Lymnaea may not be considered an optimal model system to investigate the 
directional behaviour of single growth cones in response to guidance cues. Growth cones of 
the CNS were found to be slow and sensitive to external disruptions.  
Cultured Lymnaea neurons were found to be a better model system for investigating 
the cellular mechanisms underlying the tropic effects of retinoic acid on neurite outgrowth. 
Large growth cones could be observed at the tips of regenerating neurites of cultured cells. 
This makes it possible to work directly on these growth cones and to easily manipulate and 
observe changes in their morphology and behaviour. Moreover, the growth cones of cultured 
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Lymnaea motorneurons can continue to grow after transection, allowing us to study the 
autonomy of the growth cone (Farrar et. al., 2009). Another advantage of using this model 
system is the ability to observe local effects of guidance cues and the involvement of protein 
synthesis, as previously done by Farrar et. al. (2009). Cultured neurons may, therefore, be the 
optimal system to continue to investigate the fundamental pathway(s) through which retinoic 
acid elicits its tropic effects.  
Previous findings from cultured Lymnaea neurons have shown that both retinoic acid 
isomers similarly induce and enhance neurite outgrowth as well as induce growth cone 
turning in Lymnaea neurons, in vitro (Dmetrichuk et. al., 2006; 2008). Previous findings 
have strongly suggested an important role for both retinoid receptors, LymRXR and 
LymRAR, in the chemoattractive effects of retinoic acid on growth cone guidance (Carter et. 
al., 2010, 2015). In this thesis, we have provided further evidence suggesting that the RXR 
and RAR may indeed be involved in this chemoattractive response to retinoic acid, as various 
synthetic retinoid receptor agonists mimicked effects of atRA. However, binding studies still 
need to be performed to verify the binding of the synthetic retinoids to the various retinoid 
receptors in Lymnaea.   
Aside from the proposed role of retinoid receptors, far less is known of potential 
downstream effectors involved in the chemoattractive effects of retinoic acid. Retinoic acid-
mediated growth cone turning has been shown to require both local protein synthesis and 
calcium influx (Farrar et. al., 2009). However, the downstream effectors that are involved in 
growth cone turning have not been identified. We have shown, for the first time in any 
species, that the intracellular signaling pathway involved in retinoic acid-induced growth 
cone turning involves the Rho GTPase, Rac. My findings, however, have shown that the 
involvement of Rac in growth cone turning may differ depending on whether the turning is 
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induced by endogenous or synthetic retinoids, and whether the growth cones are still attached 
to the cell body.  
The mechanism of action of Rac and the signaling pathway involved will still need 
further study and identification. We found that Rac inhibition induces a switch in growth 
cone response to atRA (from chemoattraction to chemorepulsion). A similar switch in the 
Xenopus’s growth cone response to the chemoattractant BDNF was observed after the 
inhibition of all three Rho GTPases (Yuan et. al., 2003), or after pharmacological 
manipulation of cAMP or cAMP-dependent kinases (Song et. al., 1998). These findings 
suggested that the switch in response to atRA may be a result of an interaction between Rac 
and cAMP levels within the growth cone. Therefore, future studies could investigate a 
possible interaction between Rac and cAMP, by inhibiting intracellular cAMP production 
during growth cone turning behaviors before and after Rac inhibition. Additionally, future 
studies will need to examine possible downstream effectors through which Rac likely 
regulates cytoskeletal changes in the growth cone. Future experiments could also investigate 
the potential role of other Rho GTPases such as Cdc42 or Rho (which has been suggested to 
mediate growth cone collapse) in retinoic acid-induced growth cone turning behaviour in 
Lymnaea. Furthermore, retinoid isomers (atRA and 9-cis RA) have different effects on the 
intracellular calcium levels (Vesprini et. al., 2015), and may activate different intracellular 
signaling pathways, in Lymnaea neurons. Therefore, potential differences in the role of Rho 
GTPases in growth cone turning behaviour to different isomers could also be investigated.  
Individual growth cone turning assays with retinoic acid have only previously been 
reported with invertebrate neurons. However, there is now evidence that atRA and 9-cis RA 
have similar trophic and chemotropic effects on cultured embryonic spinal cord neurons of 
Xenopus laevis (Rand et. al., 2017). Rand et. al. (2017) also provided evidence suggesting a 
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potential role for the RARβ sub-type and an RXR in the atRA and 9-cis RA-induced growth 
cone turning, respectively. Lymnaea neurons, however, were still easier to work with to 
investigate the tropic effects of retinoic acid on neurite outgrowth than cultured Xenopus 
neurons. Taken together, these findings support a role for retinoid signalling in guiding 
neurite outgrowth during regeneration, and could suggest a conservation of retinoid 
signalling pathways between vertebrates and invertebrates.  
Currently, we are among the few researchers (to our knowledge) investigating the 
cellular mechanisms involved in the chemoattractive effects of retinoic acid on growth cone 
guidance. The novel findings presented in this thesis provide a basis for future studies to 
continue to investigate the intracellular signalling pathways involved in the effects of retinoic 
acid on neurite outgrowth. The research conducted in our lab, combined with published 
findings, can help discern these mechanisms and ultimately provide progress in 
understanding processes involved in the effects of retinoic acid during regeneration. 
 
 
 
 
 
 
 
 
 
 
 
100 
 
Appendix 1: 
Fewer nerves exhibit neurite outgrowth at lower concentrations of atRA. The proportion (%) 
of floating nerves that exhibited outgrowth in the presence of DMSO, 9-cis RA, and atRA in the 
bath was determined at both concentrations (10-6M and 5x10-7M). Only floating nerves were 
counted, as those submerged do not exhibit outgrowth.  
These data were re-analyzed, with the kind help of G. Tattersall, using generalized linear mixed 
effect models, accounting for the influence of brain “identity” (i.e. which CNS it originated from) 
as a random effect. Statistical analyses were performed using R software (© The R Foundation). 
When nerve identity was accounted for, a type-II Wald Chi-square test showed a significant 
effect of condition (retinoid treatment) but only when the concentration of retinoid was 
considered. The findings of this R analysis were similar to those mentioned previously (on page 
45), which showed there was a significant effect of the condition (retinoid treatment) but only at 
lower concentrations.   
 Chi square value Degrees of Freedom Significance Value 
Concentration of 
Retinoids 
6.47 1 0.011 
Condition 
(either retinoid or 
vehicle) 
4.62 2 0.099 
Concentration x 
Condition 
8.11 2 0.017 
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Appendix 2: 
Retinoids do not increase the mean length of neurite outgrowth. The maximal length of 
neurite outgrowth observed in each condition (DMSO, 9-cis RA, and atRA in the bath) was 
determined at both concentrations (10-6M and 5x10-7M). Only floating nerves were counted as 
those submerged do not exhibit outgrowth.  
These data were re-analyzed, with the kind help of G. Tattersall, using generalized linear mixed 
effect models, accounting for the influence of brain “identity” (i.e. which CNS it originated from) 
as a random effect. Statistical analyses were performed using R software (© The R Foundation). 
A type-II Wald Chi-square test showed no significant effect of treatment. These data confirmed 
there was no significant effect of condition on the maximal length of neurite outgrowth of 
floating nerves at the different concentrations, when nerve identity was accounted for. The 
findings of this analysis were similar to the findings mentioned previously (on page 47) analyzed 
using a One Way ANOVA. 
 Chi square value Degrees of Freedom Significance Value 
Concentration of 
Retinoids 
1.49 1 0.22 
Condition   
(either retinoid or 
vehicle) 
0.11 2 0.95 
Concentration x 
Condition  
3.42 2 0.18 
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Appendix 3: 
Description of the retinoid receptor agonists used in this study.  
Retinoid  
Receptor  
Agonist 
Chemical  
Structure 
Chemical Name Alternative 
Names 
Chemical 
Formula 
Molecular 
Weight 
(g/mol) 
 
atRA 
 
 
3,7-Dimethyl-9-
(2,6,6-trimethyl-
1-cyclohexen-1-
yl)-
2E,4E,6E,8E,-
nonatetraenoic 
acid 
 
Retinoic Acid  
 
Tretinoin 
 
 
C20H28O2 
 
 
300.44 
9-cis RA  
 
 
3,7-dimethyl-9-
(2,6,6-
trimethylcyclohe
xen-1-yl) -
2E,4E,6Z,8E- 
nonatetraenoic 
acid 
 
9-cis-
Tretinoin 
 
Alitretinoin 
 
C20H28O2 
 
 
300.44 
 
EC23 
 
 
 
4-[2-(5,6,7,8-
Tetrahydro-
5,5,8,8-
tetramethyl-2-
naphthalenyl) 
ethynyl]benzoic 
acid 
 
AGN190205 
 
BASF 46928 
 
C₂₃H₂₄O₂ 
 
332.44 
 
CH55 
 
 
 
 4-[(1E)-3-[3,5-
bis(1,1-
Dimethylethyl)p
henyl]-3-oxo-1-
propenyl] 
benzoic acid 
  
C24H28O3 
 
364.47 
 
SR11237 
 
 
 
4-[2-(5,6,7,8-
Tetrahydro-
5,5,8,8-
tetramethyl-2-
naphthalenyl)-
1,3-dioxolan-2-
yl]-benzoic acid 
 
BMS 649 
 
C24H28O4 
 
380.48 
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Appendix 4: 
Transactivation Activity of RAR/RXR selective retinoids. This table represents the 
transcriptional activation activity of retinoids for the three subtypes of each RAR and RXR 
receptor. The half maximal effective concentration (EC50) or dissociation constant (K d) values 
were reported from various sources.  
The retinoid receptors were obtained from different sources, and different receptor expression 
vectors and retinoid response element-reporter constructs were used to assess relative 
transactivation activity. Hence, the transactivation activity for the same retinoids, within a 
receptor subgroup, may not be the same as that found if all of the retinoids were evaluated in the 
same assays. Nevertheless, the relative receptor selectivity, compared to other retinoids, should 
be consistent. In summary, CH55 possess higher affinity for all three subtypes of RAR and EC23 
possesses higher affinity for RARα and RARβ, compared to atRA and 9-cis RA. Although 
SR11237 possess lower affinity for RXRα compared to 9-cis RA, SR11237 was still found to be 
an effective activator of RXRα. Empty cells represent EC50 or K d  values that were not 
determined and NB represents no binding.  
Retinoid 
Receptor 
Agonist 
Retinoid receptors  
RARα RARβ RARγ RXRα RXRβ RXRγ 
 
Reference: Charton et. al., 2009; EC50 (nm) 
EC23 0.6 0.3 0.6    
atRA 17 12 0.2    
 
Reference: Haffez et. al., 2017; EC50 (nm) 
EC23 3.7 3.3 16.8    
atRA 16 17.6 14.7    
9-cis RA 28.8 27.5 36.7    
 
Reference: Sun et. al., 1997; K d (nm)  
CH55 0.44 0.04 1.7    
atRA 16 7 3 530 NB NB 
9-cis RA 22 11 20 8.4 7.4 13 
 
Reference: Dawson et. al., 1995; EC50 (nm)   
SR11237  55  34   
atRA 54 4.5 2 530   
9-cis RA  23 2.6 4.3 6   
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Appendix 5: 
Methods for measuring the proportional area occupied by regenerative processes (%) in 
ImageJ software. Highlighted in bold are the menu bar options and tools clicked in ImageJ. 
 
(1) The ImageJ program was opened 
 
 
(2) File Open Images of regenerative processes were chosen from folder 
Note: All images had been taken at the same magnification (10x) 
  
 
(3) Images were spatially calibrated so that distances measured in the image 
were measured in µm, as shown below: 
 
Analyze Set Scale Values were adjusted as below then OK was clicked: 
 
 
 
(4) Next, to ensure the percent of area occupied by regenerative processes (%) 
was measured within the same specified area, a circle with an area of 
135620μm2 was drawn and saved into the ImageJ program. This allowed for this 
same “circle” (of equal area) to be retrieved for conducting measurements in 
each image. The “circle” was drawn and saved into the ImageJ program as 
follows: 
 
Plugins Macros Record 
Oval Selection Tool was chosen A circle was drawn Analyze Measure 
The area displayed was 135620μm2 
 
Next, the Create option was clicked in the Recorder tab File Save as The 
circle was saved as a file on the computer to be easily retrieved for use 
afterwards 
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To retrieve the circle: 
PluginMarcos Run The file name of the circle that it had been saved as 
was chosen 
 
 
(5) The circle was then moved, using the mouse, such that the circle encompassed 
the neurite outgrowth and the center of the circle aligned with the center of the 
cut nerve ending. 
 
 
(6) The neurite outgrowth was highlighted in white and the background was 
eliminated, to allow for measuring the percent of area occupied by only the 
neurite outgrowth (%) within the specified area. This was conducted as 
mentioned below: 
 
Process Sharpen 
 
ProceesFind Edges 
 
Image Adjust Threshold Apply 
 
 
(7) Finally, the area occupied by the neurite outgrowth within the specified circle 
was measured: 
Analyze Measure The value recorded under Percent Area represented the 
percent of area occupied the neurite outgrowth highlighted in white (%) 
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